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Abstract
About 11% of infants are born preterm (before 37 weeks of gestation) worldwide. Adults born
preterm with very low birth weight show enhancement of cardiometabolic risk factors such as
elevated blood pressure and impaired glucose regulation compared with their peers born at term.
Not all the cardiometabolic risk factors related to preterm birth are known, or whether they apply
to those born less preterm, although about 80% of premature infants are born late preterm.
The association between preterm birth and cardiometabolic risk factors in adolescence and
adulthood was investigated in three cohort studies: The Helsinki Study of Very Low Birth Weight
Adults, the Northern Finland Birth Cohort 1986, and the ESTER study.
Preterm birth over its whole range has a long-term impact on a child’s health in later life: adults
born preterm with very low birth weight had lower resting energy expenditure, but higher resting
energy expenditure per unit lean body mass than their peers born at term. Adolescent girls born
before 34 weeks of gestation had higher blood pressure and boys have elevated levels of LDL
cholesterol and apolipoprotein B. Adults born preterm were more likely to be obese and to have
hypertension or metabolic syndrome than their peers born at term. In addition to conventional
biomarkers of cardiometabolic disorders, they had alterations in other cardiometabolic
biomarkers, such as uric acid and liver transaminases.
Adolescents and adults born preterm are at greater risk of developing cardiometabolic
disorders than their peers born at term. Most of the cardiometabolic risk factors related to preterm
birth are modifiable. Favorable early life circumstances of premature infants, such as optimal
nutrition and reduction of stress in neonatal intensive care units, might reduce the risk of later
cardiometabolic disorders. In addition, children and adults born preterm might particularly benefit
from primary prevention such as screening for additional risk factors and promotion of healthy
lifestyles.
Keywords: cardiometabolic risk factor, metabolic syndrome, premature infant, preterm
birth
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Tiivistelmä
Noin joka yhdeksäs lapsi maailmassa syntyy ennenaikaisesti, ennen 37. raskausviikkoa. Kesko-
sena syntyneillä aikuisilla on todettu enemmän joitakin sydän- ja verisuonisairauksien riskiteki-
jöitä kuin heidän täysaikaisena syntyneillä ikätovereillaan. Näistä eniten on tutkittu etenkin
kohonneen verenpaineen ja heikentyneen sokerin siedon esiintyvyyttä, mutta kaikkia myöhem-
pien sairauksien riskitekijöitä ei tunneta. Suurin osa aiemmista keskostutkimuksista on tehty
hyvin tai erittäin ennenaikaisesti syntyneillä, vaikka yli 80% keskosista syntyy lievästi ennenai-
kaisena. Ei ole juurikaan tutkimuksia siitä, ovatko sydän- ja verisuonitautien riskitekijät lisäänty-
neet myös tässä suuressa lievemmin ennenaikaisesti syntyneiden joukossa.
Eriasteisen ennenaikaisen syntymän vaikutuksia nuoruus- ja aikuisiän sydän- ja verisuonitau-
tien riskitekijöihin tutkittiin kolmessa kohorttitutkimuksessa: Helsingin Pikku-K -tutkimukses-
sa, Pohjois-Suomen syntymäkohortti 1986 -tutkimuksessa sekä ESTER-tutkimuksessa.
Ennenaikaisella syntymällä sinänsä on pitkäaikaiset vaikutuksen syntyneen lapsen tervey-
teen myös nuoruudessa ja aikuisuudessa: Hyvin pienipainoisena ennenaikaisesti syntyneillä on
korkeampi lepoenergian kulutus rasvatonta painoyksikköä kohden kuin täysiaikaisena syntyneil-
lä ikätovereilla. Hyvin ennenaikaisena (ennen 34. raskausviikkoa) syntyneillä tytöillä on 16-vuo-
tiaina korkeampi verenpaine, ja pojilla suuremmat LDL-kolesterolin ja apolipoproteiini B:n
pitoisuudet. Keskosena syntyneet puolestaan täyttivät aikuisina todennäköisemmin lihavuuden,
verenpainetaudin ja metabolisen oireyhtymän kriteerit. Perinteisten sydän- ja verisuonitautien
riskitekijöiden lisäksi heillä oli muutoksia myös monissa muissa sydän- ja verisuonitautien
merkkiaineissa, kuten uraatin ja maksa-arvojen pitoisuuksissa.
Ennenaikaisesti syntyneillä nuorilla ja aikuisilla on suurentunut riski sairastua sydän- ja veri-
suonitauteihin myöhemmällä iällä. Näitä riskejä on mahdollista ennaltaehkäistä, minkä vuoksi
ennenaikaisesti syntyneet nuoret ja aikuiset voivat hyötyä terveellisistä elämäntavoista erityisen
paljon.
Asiasanat: ennenaikainen syntymä, keskonen, metabolinen oireyhtymä, sydän- ja
verisuonitaudit
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1 Introduction 
Each year, 14.9 million infants worldwide, approximately one in nine live-born, are 
born preterm, i.e. before 37 weeks of gestation (Goldenberg et al.. 2008, Blencowe et 
al.. 2012, EUROCAT 2013). In Finland the proportion of premature infants is 
smaller, 5.7% of all infants in 2013 (Vuori & Gissler 2014). Owing to the 
development of neonatal intensive care in recent decades, the prognosis of infants 
born preterm has changed dramatically and most of them survive to adulthood. 
However, compared with the natural environment of the fetus, preterm infants 
continue their development and growth in a substantially different environment 
such as a neonatal intensive care unit (NICU). A growing body of evidence shows 
that pre- and postnatal events have long-lasting effects on a child’s health: those 
born smallest and most immature, such as those born with very low birth weight 
(<1500 g) or very preterm (before 32 weeks of gestation), show enhancement of 
cardiometabolic risk factors as adults, for example elevated blood pressure (Hack et 
al. 2005, Hovi et al. 2010, Keijzer-Veen et al. 2010b, de Jong et al. 2012, Parkinson 
et al. 2013), impaired glucose regulation (Hofman et al. 2004, Hovi et al. 2007), and 
atherogenic lipid profiles (Parkinson et al. 2013). However, most of this evidence is 
limited to these conventional cardiometabolic risk factors in the extreme groups of 
adults with very low birth weight or born very preterm. 
Most (about 70–80%) preterm infants are born moderately (at 32–36 weeks of 
gestation) or late preterm (at 34–36 weeks of gestation) (EUROCAT 2013, Martin et 
al. 2013, Vuori & Gissler 2014). However, only a few studies concerning adult 
cardiometabolic risks have included the whole range of preterm births. The results of 
these studies suggest that a linear relationship exists between shorter length of 
gestation and higher blood pressure in adulthood (Järvelin et al. 1993b, Johansson et 
al. 2005). If a similar “dose-response” relationship exists as regards other 
cardiometabolic risk factors, even moderately increased risks in the much larger 
group of people born late or moderately preterm could potentially reflect a larger 
public health burden.  
The focus of this thesis was to evaluate the association between preterm birth and 
cardiometabolic risk factors in healthy adolescents and adults in three cohort studies, 
using conventional risk factors, such as body mass and blood pressure, the established 
components and criteria of metabolic syndrome, as well as emerging risk factors that 
may reflect specific pathophysiological pathways, such as resting energy expenditure, 
body composition, plasma apolipoproteins, uric acid, and markers of inflammation 
and fatty liver disease.  
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2 Review of the literature  
2.1 Preterm birth  
Normal pregnancy usually takes an average of 40 weeks (or 280 days) counted from 
the beginning of the woman’s last menstrual period. However the range in length of 
gestation of live-born infants is wide, from 22 to over 43 weeks (Fig. 1). It is based on 
the assumption that the length of the menstrual cycle is 28 days and ovulation occurs 
on the 14th day after the last menstrual period. However, there are several limitations 
of dating based on last menstrual period, such as uncertainty regarding the last 
menstrual period date, menstrual disturbances including oligomenorrhea and delayed 
ovulation and bleeding disturbance in early pregnancy. In recent decades it has 
become increasingly common to verify the expected delivery date by means of 
ultrasonography, usually in the first trimester, or at the latest before 20 weeks of 
gestation.  
 
Fig. 1. Gestational age distribution of live-born infants in Finland in 2013 (Vuori & Gissler 
2014).  
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According to the International Classification of diseases: tenth revision (ICD-10) a 
live birth occurs when a fetus, irrespective of gestational age, exits the maternal body 
and subsequently shows any sign of life, such as voluntary movement, heartbeat, or 
pulsation of the umbilical cord, for however brief a time and regardless of whether the 
umbilical cord or placenta are intact (World Health Organization 2004). The cut-offs 
for live birth vary between countries from 20 to 28 weeks (Blencowe et al. 2012). In 
Finland the cut-off for live birth is 22+0 gestational weeks or birth weight ≥ 500 g 
(Vuori & Gissler 2014). According to the number of completed gestational weeks 
World Health Organization (WHO) categorizes births in three groups:  
– preterm (<37 gestational weeks) 
– term (37 to 41 gestational weeks) 
– post-term (≥42 gestational weeks). (WHO 1977)  
An infant born too early (before 37 full gestational weeks) is called a preterm or 
premature infant. Preterm birth is also traditionally categorized in smaller groups 
according to length of gestation:  
– extremely preterm (<28 weeks) 
– very preterm (28 to 31 weeks) 
– moderately preterm (32 to 36 weeks) (Engle et al. 2007, Blencowe et al. 
2012). 
As most preterm infants are born at between 34 to 36 weeks, moderate preterm birth 
was further split to focus on late preterm birth (34 to 36 completed weeks) by the 
American College of Obstetricians and Gynecologists (Engle et al. 2007).  
Especially before the time when ultrasonography was widely used, categorization of 
preterm infants was based on birth weight: 
– extremely low birth weight, ELBW (<1000 g) 
– very low birth weight, VLBW (<1500 g) 
– low birth weight, LBW (<2500 g). 
However, in this categorization low birth weight can be due to prematurity or being 
born small for gestational age, or both. Birth weight in relation to gestational age has 
been used as an indicator of intrauterine growth (Lee et al. 2003). There are several 
national criteria used and they are very different from each other (Hadlock et al. 1991, 
Ioannou et al. 2012, Papageorghiou et al. 2014):  
 25 
– small for gestational age, SGA (more than two standard deviations (SDs) 
below the mean, or <10th percentile) 
– appropriate for gestational age, AGA (within ± 2SDs around the mean, or 
within the 10th and 90th percentiles) 
– large for gestational age, LGA (more than 2SDs above the mean, or >90th 
percentile). 
2.1.1 Causes of preterm birth 
The obstetric precursors of preterm delivery are categorized in three groups: 1) 
spontaneous labor (40–45% of preterm births), 2) rupture of membranes (25–30% of 
preterm births), and 3) “indicated”/iatrogenic labor (30–35% of preterm births) in 
conditions that threaten the health or life of the mother or fetus (Goldenberg et al. 
2008). Preterm birth is thought to be a pathological condition or syndrome with 
multiple etiologies including inflammation, infection, uteroplacental ischemia or 
hemorrhage, uterine over-distension, stress, and an immunological process (Romero 
et al. 2006). The etiology is not fully understood and a precise mechanism cannot be 
defined in most of the cases.  
The risk factors of preterm birth include demographic characteristics, medical 
history and lifestyle, pregnancy history, and medical conditions in the present 
pregnancy (1.1.1.1.Table 1). Some of these risk factors may not be related to preterm 
birth independently and preterm birth may be the outcome of the interaction of several 
risk factors. There is also evidence of a genetic background to birth timing (Plunkett 
et al. 2009) and spontaneous preterm birth (Plunkett & Muglia 2008, Wilcox et al. 
2008, Haataja et al. 2011): women with a history of preterm labor have a more than 5-
fold risk of preterm labor in the next pregnancy (Bezold et al. 2013). The results of 
register studies concerning siblings, half-siblings and/or twins have suggested that 
both maternal and fetal genes have an effect on the length of gestation and/or the risk 
of preterm birth (Lunde et al. 2007, York et al. 2013).  
Although there have been many efforts to predict and prevent preterm birth, 
means to avoid prematurity are scanty. Screening and minimization of the risks, for 
example by treatment of bacterial vaginosis or urinary tract infections, may help in 
reaching the optimal length of gestation. Bed rest has been a traditional non-
pharmacologic treatment to prevent preterm births, but there is a lack of evidence for 
its effectiveness. In addition, tocolytic therapy can be used to inhibit contractions in 
cases of threatened preterm labor (Committee on Practice Bulletins—Obstetrics 
2012). 
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Table 1. Risk factors of preterm birth.  
Characteristics of the of mother 
Low socioeconomic status or low educational attainment 
Age <18 or >35 years 
Low body mass index or poor nutritional status 
Unmarried life 
Smoking, alcoholism or drug use 
Hard working conditions 
High levels of psychological or social stress or exposure to objectively stressful conditions 
Depression 
Chronic disease 
Ethnic background  
Pregnancy history 
Primipara 
Previous second-trimester miscarriage or stillbirth 
Previous preterm labor or infant with low birth weight 
Previous operation of uterine cervix 
Present pregnancy 
Multiple pregnancy 
Cervical insufficiency 
Low inter-pregnancy interval (< 6 months) 
Polyhydramnion or oligohydramnion 
Abdominal surgery in the second or third trimester 
Contractions 
Placenta previa 
Placental abruption 
Hypertensive pregnancy disorder 
Intrauterine growth retardation or malformation 
Hepatic cholestasis of pregnancy 
Vaginitis or cervicitis 
Premature rupture of membranes 
References: Olsen et al. 1995, Goldenberg et al. 2008, Blencowe et al. 2012, Romero et al. 2014. 
2.1.2 Epidemiology of preterm birth 
More than one in ten of all infants are born preterm: the worldwide prevalence of 
preterm birth is 11.1%, i.e. 14.9 million births in 2010. However, the prevalence 
ranges from 5% to 18% depending on the country (Blencowe et al. 2012). For 
example, in Europe the rate varies from about 5% to 10% (EUROCAT 2013). In 
Finland it has been low and relatively stable during the last ten years, being highest 
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(6.3%) around 2000, and in 2013 it was 5.7% (Vuori & Gissler 2014). In 2010 the 
highest rates of preterm birth were in Southeast Asia (13.6%), South Asia (13.3%), 
and Sub-Saharan Africa (12.3%) (Blencowe et al. 2012). The USA also has a high 
preterm birth rate (12%) (Blencowe et al. 2012, Martin et al. 2013). There are also 
differences in preterm birth rates between ethnic groups within countries: for example 
among black Americans the rate was as high as 17.5%, when the rate was 10.9% 
among white Americans (Blencowe et al. 2012). The incidence of preterm birth is 
rising worldwide (Blencowe et al. 2012, Zeitlin et al. 2013).  
Most preterm infants are born late preterm: For example in Finland 75.5% of 
preterm infants (and 4.2% of all infants) were born late preterm in 2013 (Vuori & 
Gissler 2014) and in the USA the rate was 70.8% (8.5% of all infants) in 2010 (Fig. 2) 
(Martin et al. 2013).Preterm birth is more common among boys than girls – about 
55% of all preterm infants are boys (Zeitlin et al. 2002). Boys born preterm are also at 
a higher risk of neonatal mortality and long-term impairment (Smith 2000, Stevenson 
et al. 2000, Kent et al. 2012).  
Fig. 2. Proportions of early and late preterm births of all births in Finland (2011–2012) 
and the United States of America (2010) (Martin et al. 2013, Vuori & Gissler 2013).  
Mortality related to preterm birth 
The intensive care of neonates born preterm has improved remarkably since the 
1960s. In the late 1960s assisted ventilation was introduced, in the 1970s the use of 
antenatal and postnatal glucocorticoids was started and in the 1980s the use of 
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exogenous surfactant started to prevent bronchopulmonary dysplasia and many other 
conditions (Philip 2005). Most of the treatments were primarily focused on improving 
the outcomes related to pulmonary problems. However, monitoring of the infant by 
physiological and biochemical measurements the ability to provide nutrition 
intravenously, and pharmacological manipulation were also important (Philip 2005). 
In addition to advances in technology, skin-to-skin care (kangaroo mother care) and 
breastfeeding have reduced infant mortality and morbidity (Lawn et al. 2010, 
Flacking et al. 2012). However, over one million infants every year die as a result of 
complications related to preterm birth. It is estimated that every third neonatal death 
(<28 days after birth) is caused by preterm birth and it is the largest direct cause of 
neonatal mortality and the second most common cause of death after pneumonia in 
children under 5 years old (Liu et al. 2012). In the U.S. in 2010, 35.2% of infant 
deaths were related to preterm birth (Mathews & MavDorman 2013) and in Europe 
the neonatal mortality of infants born at <32 weeks accounts for 48% of all neonatal 
deaths (EUROCAT 2013). Overall neonatal mortality is highest in developing regions 
including Southeast Asia. However, the proportion of deaths related to preterm birth 
is similar worldwide, about 30–36% of all neonatal deaths (Liu et al. 2012). In 
Finland the perinatal mortality rate in preterm infants was 3.8% as in all infants it was 
0.35% in 2013 (Vuori & Gissler 2014).  
Most neonatal deaths occur during the 7 days after birth (“early neonatal” or 
perinatal mortality). Gestational age correlates negatively to the perinatal and neonatal 
mortality rate (Fig. 3). In infants born at <34 weeks the perinatal mortality rate was 
3.5% and in infants born at 34–36 gestational weeks the rate was 0.6% in Finland in 
2012. Although infants born late preterm are often referred to as “near term”, 
mortality rates are higher than in term infants. For example, in the United States the 
mortality rate of late-preterm infants was found to be 4.6 times higher than in term 
infants (Engle et al. 2007). Those born preterm have an increased risk of mortality 
throughout childhood, but not in adolescence (Swamy et al. 2008, Crump C 2011). 
Again, in young adulthood, preterm birth has been associated with increased 
mortality, even among individuals born late preterm (Crump C 2011). In spite of 
increased mortality rates, most infants born preterm survive to adulthood. 
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Fig. 3. Perinatal mortality rate by gestational age in weeks in Finland in 2013 (Vuori & 
Gissler 2014).  
Morbidity related to preterm birth 
Despite the developments in intensive care of preterm infants in past decades, preterm 
survivors still have higher morbidity rates than infants born at term. Some of the 
factors associated with preterm birth, such as intrauterine growth retardation (IUGR), 
are related to morbidity of preterm infants. However, preterm infants are exposed to a 
very different environment in their first weeks of postnatal life than if they would 
have been in utero till term. In addition, most organs, such as the lung, brain and 
kidneys, are immature and especially susceptible to the consequences of preterm birth 
(Saigal & Doyle 2008). As with neonatal mortality, morbidity rates are also lower the 
higher the gestational age is at birth (Bastek et al. 2008). However, late-preterm 
infants are much more likely to show newborn morbidity than term infants (Bastek et 
al. 2008, Committee on Obstetric 2008, Saigal & Doyle 2008, Shapiro-Mendoza et al. 
2008, Kugelman & Colin 2013). Common neonatal complications of preterm 
neonates are presented in Table 2.  
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In the first years of life, children born preterm with VLBW, and also those born 
late-preterm, have more hospital readmissions than children born at term. Rates of 
acute hospitalization decreases in adolescence (Saigal et al. 2001, Bird et al. 2010, 
Korvenranta et al. 2010) and in early adulthood rates of hospitalization are similar to 
those among term-born peers (Saigal et al. 2007), though they have higher rates of 
chronic conditions than controls (Hack et al. 2002). The most frequently occurring 
medical conditions in children and adults born preterm are asthma, recurrent 
bronchitis, cerebral palsy, mental retardation, neurosensory impairment, and epilepsy 
(Hack et al. 2002, Saigal et al. 2007, Moster et al. 2008, Korvenranta et al. 2010). 
However, most of those who survive after preterm birth to reach adolescence and 
adulthood are healthy. 
Table 2. Common neonatal complications after preterm birth. 
Respiratory distress syndrome and bronchopulmonary dysplasia 
Persistent pulmonary hypertension of newborns 
Pneumothorax 
Patent ductus arteriosus 
Apnea/bradycardia 
Hyperbilirubinemia 
Intraventricular or periventricular hemorrhage 
Sepsis and other infections 
Temperature instability 
Hypoglycemia 
Dehydration 
Feeding difficulties and under-nutrition 
Necrotizing enterocolitis 
References: Wang et al. 2004, Philip 2005, Engle et al. 2007, Saigal & Doyle 2008. 
2.2 Cardiometabolic risk factors 
Cardiometabolic risk refers to a high lifetime risk for cardiovascular disease 
(CVD) (Sipola-Leppänen et al. 2015). CVDs include diseases of the heart, 
vascular diseases of the brain, and diseases of blood vessels. They can be 
categorized into two groups according to their etiology to those developed as a 
result of atherosclerosis (ischemic heart disease or coronary artery disease, 
cerebrovascular disease, diseases of the aorta and arteries – including 
hypertension and peripheral vascular disease) and others (congenital heart 
disease, rheumatic heart disease, cardiomyopathies, cardiac arrhythmias) (Mendis 
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et al. 2011). The present work is concentrated on cardiovascular disease risks 
related to atherosclerosis. Atherosclerosis is the underlying complex pathological 
process in the walls of blood vessels that results in coronary heart disease and 
cerebrovascular disease.  
Table 3. Conventional cardiometabolic risk factors. 
Behavioral 
Tobacco smoking, including second-hand smoke 
Physical inactivity 
Unhealthy diet (e.g. rich in salt and calories) 
Harmful use of alcohol 
Metabolic risk factors 
Raised blood pressure 
Raised blood sugar 
Dyslipidemias 
Overweight and obesity 
Inflammation 
Hypercoagulation 
Other 
Low socioeconomic status 
Advancing age 
Male sex 
Genetic disposition 
Psychological factors (e.g. stress, depression) 
Air pollution 
References: Berenson et al. 1998, Brunzell et al. 2008, Mendis et al. 2011, Lim et al. 2012. 
Atherosclerosis starts to develop as early as in childhood and adolescence due to 
the overall effect of a number of risk factors (presented in Table 3) (Järvisalo et 
al. 2001, Raitakari et al. 2003, Koskinen et al. 2009, Lewandowski et al. 2014). 
Behavioral and metabolic risk factors play a key role in the etiology of 
atherosclerosis (Mendis et al. 2011). Previous studies have shown that the fetal 
period and childhood have a substantial effect on an individual’s risk of later 
cardiovascular disease (see section 2.3). CVDs are the leading cause of death 
worldwide, representing about 30% of all deaths globally and 47% of all deaths in 
Europe, and the numbers are increasing (World Health Organization 2011, 
Nichols et al. 2012). In Finland ischemic heart disease causes more than every 
fifth death (21%, about 11,000 deaths [add time period], 53% men), though the 
 32 
numbers have decreased in the past twenty years (Statistics Finland 2012). Most 
cardiovascular diseases could be prevented by reducing the risk factors. 
Metabolic syndrome is a combination of factors that multiply a person's risk of 
heart disease, diabetes and stroke (Lakka et al. 2002, Onat et al. 2002). The risk 
factors include central (abdominal) obesity, raised blood pressure, elevated fasting 
plasma glucose levels, and dyslipidemias (high serum triglyceride, and low high-
density cholesterol (HDL-C) levels). Various diagnostic criteria for metabolic 
syndrome have been in use, decided upon by different organizations (the WHO, the 
National Cholesterol Treatment panel III, the International Diabetes Foundation and 
the American Heart Association/National Heart, Lung, and Blood Institute), with the 
same risk factors but different cut-off points. However, in 2009 these major 
organizations proposed a Joint Interim Statement in an attempt to unify the criteria 
(Alberti et al. 2009). The cut-off levels of these criteria are presented in section 4.3.7. 
Obesity, particularly abdominal obesity, is a key component underlying many 
characteristics of metabolic syndrome. 
The prevalence of metabolic syndrome varies depending on the criteria used and 
the population. In 2001–2002 , among adolescents born in Northern Finland, the 
overall prevalence of metabolic syndrome according to the International Diabetes 
Foundation pediatric definition was 2.4% (95% CI 2.0 to 2.8%) and according to the 
International Diabetes Foundation adult definition the overall prevalence was lower, 
1.7% (95% CI 1.3 to 2.0%) (Pirkola et al. 2008). In Finland the overall prevalence of 
metabolic syndrome in young adults aged 24–39 years in 2001 was 10–15% and 6 
years later in 30- to 45-year-old adults it was 15–23% depending on the metabolic 
syndrome definition used. The prevalence of metabolic syndrome increased from 
1.0% to 7.5% in 24-year-old participants between the years 1986 and 2001. The 
increase was mostly driven by an increase in central obesity (Mattsson et al. 2007).  
Cardiometabolic syndrome, on the other hand, is a constellation of metabolic 
dysfunctional characteristics – cardiovascular, renal, metabolic, hemodynamic, 
prothrombotic and inflammatory abnormalities (Castro et al. 2003, Govindarajan et 
al. 2005).  
2.3 Developmental Origins of Health and Disease (DOHaD) 
In the 1980’s David Barker and his colleagues presented the theory that 
undernutrition during gestation was an important early origin of adult cardiac and 
metabolic disorders due to fetal programming that permanently shaped the body’s 
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structure, function and metabolism and contributed to adult disease (Gillman 2005, 
Barker 2007). This theory was based on epidemiological studies of birth and death 
records that revealed a high geographic correlation between rates of infant mortality 
and certain classes of later adult deaths as well as an association between birth weight 
and rates of adult death from ischemic heart disease (Barker & Osmond 1986, Barker 
et al. 1989, Barker et al. 1993). The theory is often called “Barker’s hypothesis” and 
it stimulated interest in the fetal origins of adult disorders, which expanded and led to 
the formation of an International Society for Developmental Origins of Health and 
Disease (DOHaD).  
The hypothesis has been supported by a worldwide series of animal (Mcmillen & 
Robinson 2005, Nuyt 2008) and epidemiological studies. These studies have shown 
that those who are born with low birth weight have, for example, increased incidences 
of cardiovascular disease and mortality (Barker et al. 1989, Osmond et al. 1993, 
Forsen et al. 1997, Rich-Edwards et al. 1997, Kaijser et al. 2008), higher blood 
pressure (Law et al. 1993, Law & Shiell 1996, Barker et al. 2001), increased rates of 
hypertension (Barker & Osmond 1988, Barker 1992, Huxley et al. 2000, Järvelin et 
al. 2004b, Johansson et al. 2005), and impaired glucose regulation or type 2 diabetes 
(Hales et al. 1991, Robinson et al. 1992, Barker et al. 2002, Eriksson et al. 2006, 
Whincup et al. 2008, Kaijser et al. 2009). In addition, length of gestation seems to be 
associated with mortality from cardiovascular disease (Koupil et al. 2005) and 
diabetes (Kaijser et al. 2009), which indicates similar metabolic consequences in 
adults born preterm and those born with low birth weight. 
2.4 Long-term cardiometabolic risk factors related to preterm birth 
As with morbidity and mortality in infancy, the long-term impact of preterm birth is 
usually inversely related to the gestational age at birth, with the greatest effects being 
seen in those born very or extremely preterm. Most of the relevant follow-up studies 
have been focused mainly on health during childhood.  
In Swedish cohort studies low gestational age at birth was independently 
associated with increased mortality in early childhood and young adulthood 
(Crump C 2011), and preterm birth before 32 weeks was associated with an 
almost twofold increased risk of cerebrovascular disease compared with that 
among term-born individuals, while individuals born at 32–36 weeks were not at 
increased risk (Ueda et al. 2014). In addition, in older people shorter length of 
gestation has been associated with an elevated risk of cerebrovascular disease 
(Koupil et al. 2005), but not with later ischemic heart disease (Koupil et al. 
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2005), or the association was found only when adjusted for birth weight (Kaijser et 
al. 2008). However, studies on older people might be affected by survival bias, as the 
survival rate of preterm infants was much lower several decades ago.  
Because ischemic heart disease is not prevalent in young adults, relevant studies 
are often concentrated on risk factors, not the full-blown syndrome. There are several 
cohort studies of survivors who have been followed longitudinally from birth into 
adolescence or adulthood. Most of them include subjects born with VLBW or VLGA 
and subjects have been selected according to birth weight rather than gestational age, 
mainly because gestational age was more uncertain in the era before routine antenatal 
ultrasonographic examination. In addition, those individuals whose length of gestation 
was determined ultrasonographically are now young adults.  
2.4.1 Body size and composition 
In the early postnatal period infants born preterm show substantial growth failure, 
which is usually followed by a period of catch-up growth. The catch-up starts in early 
infancy and usually stops at 2–3 years of age (Hack et al. 2003, Saigal et al. 2006). 
Despite the catch-up, adults born preterm are on average shorter (Kistner et al. 2000, 
Peralta-Carcelen et al. 2000, Weiler et al. 2002, Bonamy et al. 2005, Rogers et al. 
2005, Saigal et al. 2006, Hovi et al. 2007, Rotteveel et al. 2008a, Indredavik Evensen 
et al. 2009) and lighter (Kistner et al. 2000, Peralta-Carcelen et al. 2000, Rogers et al. 
2005, Indredavik Evensen et al. 2009) than their controls (Virhe. Viitteen lähdettä ei 
löytynyt.), and the catch-up for weight is more pronounced than that for height (Hack 
et al. 2003, Saigal et al. 2006).  
Catch-up in weight may lead to altered body composition in adulthood. For 
example, in term-born individuals, the early catch-up weight gain has been shown to 
be associated with later obesity (Ong et al. 2000), which is a key component 
underlying many characteristics of metabolic syndrome and is a major health problem 
throughout the world. Most of the studies on the body size of former preterm infants 
concern adults born with VLBW or VLGA and they have reported lower weight in 
adolescents and adults born preterm with VLBW or ELBW, which was explained by 
lower lean body mass (LBM, aka fat-free mass, Table 5) (Peralta-Carcelen et al. 
2000, Hovi et al. 2007). Although one group reported more adipose tissue in adults 
born preterm (≤33 w) (Thomas et al. 2011), two others reported no difference in body 
composition between adults born preterm (<32 wk or <1500 g) and those born at term 
(Weiler et al. 2002, Rotteveel et al. 2008a). However, in studies on adults born  
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Table 4. Mean differences (with 95% CI or P value) in body size in adolescents and 
adults born preterm compared with term-born controls. 
Authors Age Subjects Height (cm) Weight (kg) BMI 
Women       
Rogers et al. 2005 ~17 ≤800 g -7.9 (P<0.001) -2.3 (P<0.01) 0.51 (NS) 
Saigal et al. 2006 21.5—
26.5 
<1000 g -6.2 (-8.3, -4.0) -7.1 (-11.8, -2.4) -0.75 (-2.5, 0.99) 
Hack et al. 2003 ~20 <1500 g -1.2 (-3.2, 0.9) -2.0 (-6.9, 2.8) -0.5 (-2.1, 1.0) 
Hovi et al. 2007 18─27 <1500 g -5.3 (-7.3, -3.2) W: -8.5%  
(-12.9, -3.8) 
-2.4% (-6.7, 2.1) 
Rotteveel et al. 2008 ~20 <32 w -2.0 (P=0.003) -2.1 (P=0.12) 0.3 (P=0.94) 
Edstedt Bonamy et al 2005 ~16 ≤34 w -3 (P=0.03) 1 (P=0.76) 1 (P=0.23) 
Men      
Rogers et al. 2005 ~17 ≤800 g -10.2 (P<0.001) -9.1 (P<0.01) -0.35 (NS) 
Saigal et al. 2006 21.5—
26.5 
<1000 g -7.2 (-10.3, -
4.1) 
-6.5 (-11.7, -1.2) -0.15 (-1.8, 1.5) 
Hack et al. 2003 ~20 <1500 g -3.1 (-5.2, -1.1) -10.5 (-14.8, -
6.2) 
-2.6 (-3.8, -1.3) 
Hovi et al. 2007 18—27 <1500 g -5.9 (-8.3, -3.5) -12% (-16.9, -
8.8) 
-5.9% (-10.4, -
1.1) 
Rotteveel et al. 2008 ~20 <32 w -2.8 (P=0.003) 0.8 (P=0.12) 0.8 (P=0.94) 
Mathai et al. 2013 35.7 <37 w All: -1.5 
(P=0.44) 
M: 20 P=0.01) 5.8 (P=0.021) 
Women and men      
Peralta-Carcelen et al. 
2000 
14.8 (1.8) ≤1000 g -4.8 (P<0.05) -9.1 (P<0.05) NR 
Inderavik Evensen et al. 
2009 
~18 <1500 g -3.8 (P<0.01) -5.6 (P<0.01) 1.0 (NS) 
Weiler et al. 2002 16—19 <1500 g -7.3 (P<0.05) -5.7 (NS) 0.0 (NS) 
Lewandowski et al. 2013 23—28 <1850g -4.4 (P<0.001) 3.7 (P=0.33) 2.0 (P=0.003) 
Irving et al. 2000 ~24 <2000 g 2 (NS) 6.8 (NS) NR- 
Kistner et al. 2000 23—30 <32 w -3.2 (P<0.01) -4.0 (P<0.01) -0.5 (NS) 
Thomas et al. 2011 18—27 ≤33 w -0.02  
(-0.06, 0.03) 
-1.69 (-6.8, 3.4) -0.12 (-1.6, 1.4) 
Mathai et al. 2013 35.7 <37 w -1.5 (P=0.44) 5.1 (P=0.28) 2.2 (P=0.14) 
Skilton et al. 2011 ~32 <37 w NR NR 0.0 (P=0.66) 
Abbreviations: NR, not reported; NS, not statistically significant.  
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preterm within the whole spectrum of preterm birth, adults born preterm have 
been found to have a higher body mass index (BMI) and a more adipose body 
composition (Table 5) (Breukhoven et al. 2012, Lewandowski et al. 2013, Mathai 
et al. 2013). In addition, adults born preterm (<37 weeks) were more obese 
compared with those born at term (39% vs. 14%, P=0.049) (Mathai et al. 2013). 
However, some studies did not reveal any difference in body size (Irving et al. 
2000, Thomas et al. 2011, Parkinson et al. 2013), or a difference was seen only in 
men (Hack et al. 2003, Hovi et al. 2007). In addition to lower LBM and possibly 
a more adipose body composition, adults born preterm have lower bone mineral 
density (Hovi et al. 2009).  
The body composition of adolescents and adults born preterm has been studied 
by bioimpedance analysis (BIA), dual X-ray absorptiometry (DXA) and magnetic 
resonance imaging (MRI) in previous studies. MRI allows determination of 
anatomically defined compartments – for example, intra-abdominal versus 
subcutaneous fat, and is one of the “gold standard” methods to assess body 
composition. DXA is also a precise method that provides detailed information on 
body composition (Woodrow 2007). BIA is used to measure the resistance to a weak 
current (impedance) applied across extremities and provides an estimate of body fat 
using an empirically derived equation. Although compared with MRI and DXA, BIA 
is more likely to be affected by other factors such as position and posture of the 
subject, the precision of the technique is high (Woodrow 2007). DXA and BIA do not 
distinguish between visceral and subcutaneous fat tissue. 
2.4.2 Resting energy expenditure 
The mechanisms behind the altered body composition in former preterm infants 
are not clear. Lean body mass is positively related to resting energy expenditure 
(REE, or resting metabolic rate), which means the number of calories burned to 
maintain basic life functions at rest (Weinsier et al. 1992, Wang et al. 2000). 
Having a lower LBM, adults born preterm with VLBW would be expected to 
have lower REE. However, the REE of adults born preterm has not been reported 
before. There are inconsistent findings in studies comparing REE in children born 
preterm and SGA with those born preterm and AGA (Mericq et al. 2009, 
Sepúlveda et al. 2013). The association between LBW and REE in adulthood is 
also unclear: in young adults there was no statistically significant difference in 
REE between those born LBW compared with those born with normal birth 
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weight (Weitz et al. 2013). However, a study on Finnish adults (mean age 61.6 
years) showed that birth weight is positively associated with adult REE 
(Sandboge et al. 2012).  
Within-individual REE is a very stable measurement: individual variability 
ranges from 3% to 7.5% (Compher et al. 2006). However, between individuals there 
are differences in REE and the results of previous studies have suggested that these 
differences could be important contributors to the development of obesity (Ravussin 
et al. 1988, Astrup et al. 1999). REE accounts for about two thirds of daily total 
energy expenditure (Fig. 4) (Levine 2004). The remainder depends on an individual's 
thermogenesis and physical activity, the amount of which varies substantially between 
individuals according to their physical activity levels (Lowell & Spiegelman 2000). 
Young adults born preterm with VLBW were reported to have lower rates of physical 
activity energy expenditure in the Helsinki Study of Very Low Birth Weight Adults 
(HeSVA) (Kaseva et al. 2012). 
 
 
Fig. 4. Components of daily total energy expenditure. 
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2.4.3 Blood pressure 
Office-measured blood pressure 
An association between preterm birth and elevated blood pressure in later life has 
been shown in many previous studies (Table 6). Most studies on adults born preterm 
with low, very low or extremely low birth weight have shown higher systolic blood 
pressure (SBP) in preterm subjects versus controls (Irving et al. 2000, Doyle et al. 
2003, Hovi et al. 2007, Indredavik Evensen et al. 2009, Vohr et al. 2010) and higher 
diastolic blood pressure (DBP) (Irving et al. 2000, Doyle et al. 2003, Hovi et al. 2007, 
Vohr et al. 2010), and this has also been seen in adolescents (Pharoah et al. 1998). 
However, Hack et al. found no statistically significant difference in BP in adults born 
preterm with VLBW compared with controls born at term (Hack et al. 2005). Studies 
on adolescents and adults born preterm at low gestational age have shown an 
association between preterm birth and higher SBP levels in later life (Irving et al. 
2000, Kistner et al. 2000, Rotteveel et al. 2008a, Keijzer-Veen et al. 2010b, Thomas 
et al. 2011). The association is not particularly clear in studies including all subjects 
born preterm (<37 weeks) (Table 6) (Barros & Victora 1999, Singhal et al. 2001b, 
Järvelin et al. 2004a, Johansson et al. 2005, Dalziel et al. 2007, Cooper et al. 2009, 
Lazdam et al. 2010, Rossi et al. 2011, Skilton et al. 2011, Tauzin et al. 2014). In 
addition, in a meta-analysis that included 10 studies on children and adults born 
preterm (mean age 17.8 years, range 6.3–22.4 years) and a mean gestational age of 
30.2 weeks (range 28.8–34.1 weeks), the estimated office-measured SBP difference 
was 2.5 mm Hg (95% CI 1.7–3.3 mm Hg) higher among preterm subjects versus 
term-born controls (de Jong et al. 2012). In another meta-analysis that included 
preterm adults, preterm birth was associated with an elevation of SBP of 4.2 mm Hg 
(95% CI 2.8–5.7) (Parkinson et al. 2013). 
An inverse linear association between gestational age and SBP has also been 
shown. For example, -0.1 to -0.5 mm Hg changes in SBP per one-week increase in 
gestational age have been reported (Siewert-Delle & Ljungman 1998, Leon et al. 
2000, Järvelin et al. 2004b, Dalziel et al. 2007). 
A few studies have revealed higher relative risks of hypertension in adults born 
preterm compared with adults born at term, ranging from 1.2 to 2.5 (Johansson et al. 
2005, Dalziel et al. 2007, Crump et al. 2011b). In addition, in the Northern Finland 
Birth Cohort 1966, women born preterm had an approximately twofold risk of 
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gestational hypertension during their first pregnancies, but no increased risk of 
preeclampsia (Pouta et al. 2004). 
Several studies have concerned sex-specific analysis and most (Doyle et al. 2003, 
Järvelin et al. 2004b, Hack et al. 2005, Cooper et al. 2009), but not all (Rotteveel et 
al. 2008a, Thomas et al. 2011) have revealed a greater difference in women than in 
men. A statistically significant interaction between preterm birth and sex on blood 
pressure was seen in the Northern Finland Birth Cohort 1966 (Järvelin et al. 2004b). 
In brief, both women and men born preterm had higher levels of office-measured 
blood pressure than their peers born at term, but the difference was greater in women.  
Ambulatory blood pressure 
Studies on adults born preterm with VLBW (Doyle et al. 2003, Hovi et al. 2010, 
Roberts et al. 2014) and born at <28 weeks (Roberts et al. 2014) have shown elevated 
mean 24-h systolic ambulatory blood pressures (ABPs) (0). Doyle et al. (2003) 
reported a statistically significant difference in all preterm subjects born before 28 
weeks, and also a difference between women and men in a gender-specific analysis. 
Again, in the Helsinki Study of Very Low Birth Weight Adults, gender-specific 
analysis revealed a statistically significant difference in ABP in women only. A 
gender-specific association in a meta-analysis was similar: women born preterm had a 
3.5-mmHg (95% CI 1.4–5.6) higher systolic ABP than women born at term, but such 
a difference was not seen in men (Parkinson et al. 2013). In contrast, another study of 
young women born preterm (<32 weeks) did not reveal any statistically significant 
difference in ABP (Kistner et al. 2000) (0). In a study on Turkish children (5–17 y), 
preterm birth was associated with higher nocturnal systolic blood pressure, but not 
with daytime or 24-hour BP (Cruickshank et al. 2013).  
Variability of blood pressure 
The variability of ABP is less studied. In HeSVA, the variability of daytime SBP, as 
expressed by the SD of each individual’s measurements, was 1.1 mmHg (P=0.03) 
higher in men born with VLBW compared with men born at term (Hovi et al. 2010). 
In addition, a study concerning late preterm birth and BP in 4- to 13-year-old children 
revealed higher 24-hour SBP and DBP, and higher daytime SBP and nighttime SBP 
and DBP than in controls, but the investigators did not present the mean values of 
ambulatory blood pressure (Gunay et al. 2014). The variability of 24-hour BP (Parati 
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1987, Frattola 1993) and SBP when awake (Tatasciore et al. 2007) independently 
predicts organ damage, 24-hour SBP predicts atherosclerosis (Mancia et al. 2001), 
and nighttime SBP variability is associated with cardiac event incidence in 
hypertensive patients (Verdecchia et al. 1994). 
2.4.4 Lipid metabolism 
Dyslipidaemias represent a major risk as regards ischemic heart disease and stroke. 
Globally, one third of cases of ischemic heart disease is attributable to high 
cholesterol levels and hypercholesterolemia is one of the leading risk factors causing 
burden of disease (Lim et al. 2012). Previous findings concerning later life serum 
lipid levels of former preterm infants are inconsistent. Several studies have reported 
no association between preterm birth and serum lipid levels in adulthood (Irving et al. 
2000, Kistner et al. 2004, Finken et al. 2006, Rotteveel et al. 2008a, Hovi et al. 2011, 
Skilton et al. 2011, Thomas et al. 2011). However, there are also findings that have 
indicated a more atherogenic lipid profile in adults born preterm: Adults (aged 33.4–
38.0 years) born preterm (<37 w) had lower HDL-C concentrations and greater total 
cholesterol (TC) to HDL-C ratios (Mathai et al. 2013). In a British cohort study 
young adults (23–28 y) born preterm <1850 g had higher total cholesterol (TC), low-
density lipoprotein cholesterol (LDL-C) and TG levels than their peers born at term 
(Lewandowski et al. 2013). In addition, a study concerning measurement of lipids 
after a meal showed that postprandial triacylglycerol levels were increased in men 
born SGA (Rotteveel et al. 2008a). In the detailed HeSVA analysis of lipoprotein 
profiles by nuclear magnetic resonance, young adults born with VLBW had 
triglyceride-related differences in both VLDL and HDL-C subclasses compared with 
their peers born at term (Hovi et al. 2013). In a meta-analysis, adults born preterm had 
0.15 mmol/l (95% CI 0.01–0.30) higher fasting LDL-C concentrations (Parkinson et 
al. 2013), but the difference was explained with one study (Lewandowski et al. 2013).  
Furthermore, a one-week increase in gestational age (GA) has been associated 
with 0.02 mmol/l lower TC levels in women, but not in men (Cooper et al. 2009) and 
TG levels have been found to be inversely associated with GA in 11- to 15-year-old 
children (Morley et al. 2000), but not in young adults (Dalziel et al. 2007). 
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2.4.5 Glucose regulation 
Insulin resistance is a key component of type 2 diabetes and metabolic syndrome, and 
low birth weight is associated with altered glucose regulation and diabetes (Eriksson 
et al. 2006, Harder et al. 2007). However, the association between GA or preterm 
birth and altered glucose metabolism in later life is inconsistent. Some studies have 
revealed no difference in glucose regulation between adults born preterm vs. term 
(Irving et al. 2000, Skilton et al. 2011, Thomas et al. 2011), because of a lack of 
power, or a difference has been found only in those born preterm and SGA but not in 
those born AGA (Rotteveel et al. 2008a). However, studies in prepubertal children 
(Hofman et al. 2004, Kistner et al. 2012) and adults (Dalziel et al. 2007, Hovi et al. 
2007, Pilgaard et al. 2010, Mathai et al. 2012) born preterm have shown decreased 
insulin sensitivity, also shown by way of intravenous glucose tolerance tests (2004, 
Kajantie et al. 2014), and higher fasting glucose (Lewandowski et al. 2013) and 
insulin levels (Hovi et al. 2007, Lewandowski et al. 2013). Although GA was not 
found to be associated with later diabetes in Finnish children and young adults 
(Lammi et al. 2009), preterm birth increased the risk of diabetes in adulthood in other 
studies (Lawlor et al. 2006a, Kaijser et al. 2009, Kajantie et al. 2010a, Pilgaard et al. 
2010, Crump et al. 2011a).  
2.4.6 Other cardiometabolic biomarkers 
In addition to the established risk factors of cardiovascular disease listed in Table 3 
(section 2.2) and those included in the criteria of metabolic syndrome, there are many 
other measurable markers related to elevated CVD risk. Some previous studies have 
concerned unconventional cardiometabolic risk factors possibly associated with 
preterm birth and reflecting different underlying pathophysiological pathways of 
CVD. 
Inflammation seems to be a strong, independent risk factor of metabolic 
syndrome and CVD in adults (Danesh et al. 1998, Pearson et al. 2003). However, the 
predictive utility of high-sensitivity C-reactive protein (hsCRP) concentrations has 
been questioned in a previous meta-analysis (Shah et al. 2009). Some investigators 
have reported no difference in hsCRP or CRP levels in adults born preterm compared 
with adults born at term (Skilton et al. 2011, Lewandowski et al. 2013).  
Uric acid stimulates oxidative stress, endothelial dysfunction, inflammation and 
vasoconstriction and is a strong predictor of type 2 diabetes and CVD, independent of 
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metabolic syndrome components (Fang & Alderman 2000). Liver transaminases and 
non-alcoholic fatty liver disease are also biomarkers of these disorders, although the 
literature is less consistent as to whether or not they are independent indicators of 
pathology or general markers of metabolic syndrome (Sniderman et al. 2011, Lv et al. 
2013). No reports have been published concerning uric acid and liver enzymes in 
adults born preterm. However, one group reported differences in the levels of 
(premorbid) urinary biomarkers (elevated levels of methylamines and 
acetylglycoproteins; lower hippurate levels), metabolites associated with 
inflammation in young adults born preterm (≤33 w) (Thomas et al. 2011).  
2.4.7 Vascular structure and function  
Some changes in vascular structure have been reported in young adults born preterm, 
such as increased left ventricular mass and reduced function (Lewandowski et al. 
2013) and impaired retinal vascularization in women (Kistner et al. 2002). Findings 
concerning early markers of the atherosclerotic process, such as endothelial 
dysfunction or arterial stiffness in adolescents and adults born preterm are conflicting. 
Some studies have shown no association (Singhal et al. 2001b, Indredavik Evensen et 
al. 2009, Kerkhof et al. 2012, Parkinson et al. 2013), and in contrast, some studies 
have indicated a positive association (Bonamy et al. 2005, Bassareo et al. 2010, Hovi 
et al. 2011), although in one of them the finding was limited to those with concurrent 
fetal growth restriction (Skilton et al. 2011). Arterial stiffness is a key factor as 
regards increased systolic and pulse pressure in adults.  
2.4.8 Lifestyle  
Many aspects of cardiovascular disease (see section 2.2) could be prevented by way 
of a healthy lifestyle. Previous studies have suggested that the lifestyle of adults born 
preterm, at least in those born with VLBW, is different from that in adults born 
preterm. Adolescents and adults born preterm are less physically active than their 
peers born at term (Rogers et al. 2005, Hack et al. 2007, Saigal et al. 2007, Andersen 
et al. 2009, Kajantie et al. 2010b, Kaseva et al. 2012) and they have lower 
cardiorespiratory and muscle strength (Rogers et al. 2005, Saigal et al. 2007). Low 
physical activity level is a well-known risk factor of CHD and CVD (Shiroma & Lee 
2010). In addition, adults born with VLBW have reported consuming fewer fruits, 
vegetables, berries and milk products (HeSVA) (Kaseva et al. 2013). Low 
consumption of fruit has been ranked among the five most important factors causing 
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the worldwide disease burden (Lim et al. 2012). In contrast, the results of some 
studies suggest that adults born preterm are more cautious and show less risk-taking 
behavior (Hack et al. 2002, Pesonen et al. 2008), lower rates of smoking (Strang-
Karlsson et al. 2008) and use of alcohol (Hack et al. 2002, Strang-Karlsson et al. 
2008). These factors may protect them from CVD. 
2.4.9 Summary 
There is a lot of evidence that adolescents and adults born preterm have many risk 
factors for later cardiovascular disease, such as higher blood pressure, impaired 
glucose regulation, and altered body composition and lifestyle. However, the evidence 
is not that consistent as regards all cardiometabolic risk factors, e.g. energy 
metabolism, lipid metabolism and emerging cardiometabolic risk factors. In addition, 
it is not clear whether these risks are similar in those born moderately versus late 
preterm. Fig. 5 summarizes the main points of the association between preterm birth 
and later cardiometabolic risk factors. 
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3 Aims 
The present study was designed to evaluate the cardiometabolic risk factors of 
adolescents and young adults born preterm. The specific aims were: 
1. To study whether adolescents/adults born preterm differ from those born at 
term as regards cardiometabolic risk factors such as lower resting energy 
expenditure, unfavorable body composition, elevated blood pressure, higher 
plasma lipid levels, and altered glucose regulation (I–IV). 
2. To examine whether these risk factors are present and similar in 
adolescents/adults born early preterm (<34 weeks) and late preterm (34 to 36 
weeks) (II–IV). 
3. To see if these risk factors are different in men and women born preterm (I–
IV). 
4. To see if these risks are attributable to perinatal factors, childhood 
socioeconomic status or lifestyle (I–IV).  
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4 Subjects and methods 
The thesis is based on data from three different studies: 1) the Helsinki Study of Very 
Low Birth Weight Adults (I), 2) the Northern Finland Birth Cohort 1986 (NFBC 
1986, II–IV) and 3) the ESTER Preterm Birth study (“Preterm birth and early life 
programming of adult health and disease”, III, IV). Half of the subjects (585) in the 
ESTER study are also members of the NFBC 1986 cohort. 
4.1 Helsinki Study of Very Low Birth Weight Adults (I) 
The Helsinki Study of Very Low Birth Weight Adults is a prospectively collected 
longitudinal birth cohort study, the clinical assessment of which was conducted in 
2004–2005 in Helsinki. 
4.1.1 The study population 
The original study cohort consisted of 335 VLBW infants who were born between 
January 1978 and December 1985 and were discharged alive from the NICU of the 
Children’s Hospital at Helsinki University Central Hospital, the only tertiary neonatal 
care center in the province of Uusimaa, Finland (Järvenpää & Granström 1987). For 
each VLBW survivor, the next available singleton term infant (gestational age >37 
weeks), who was of the same sex and was not SGA was selected as a control.  
Most (95.1%) of the VLBW individuals and 96.8% of the controls were traced 
through the National Population Register Center of Finland. 255 VLBW individuals 
and 314 control individuals born at term who were living in the greater Helsinki area 
were invited to the first clinical visit and 166 (65.1%) of the VLBW individuals and 
172 (54.8%) of the control individuals agreed to participate. The clinical study 
participants had a lower rate of cerebral palsy at 15 months of age than the non-
participants, but otherwise they did not differ as regards perinatal and neonatal data 
(birth weight, length of gestation, maternal preeclampsia, and days of age at discharge 
from the NICU) (Hovi et al. 2007). 
In this study we included those with data on resting energy expenditure (REE) 
assessed by indirect calorimetry and body composition assessed by dual energy X-ray 
absorptiometry (DXA). REE could be measured in three of the four to five 
participants per day because there was only one calorimeter available. Subjects were 
selected randomly for the measurement and no one refused. DXA required a separate 
visit and was not carried out in participants who were pregnant or had a foreign object 
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in the body, or had severe cerebral palsy or were unwilling to undergo the 
examination. As a result, 116 VLBW individuals and 118 controls born at term had 
data on REE and DXA and were included in this study.  
We compared the subjects included in the analysis with those who did not have 
appropriate data. Included subjects did not differ from the remaining subjects who 
attended the clinical examination in any of the prenatal and birth characteristics, 
except that they were more likely to be born from a singleton pregnancy (P=0.046). In 
addition, their mean age, height, BMI, parental education, and smoking habits were 
similar. 
 
Fig. 6. Flow chart showing participants selected for the study (article I). Participants 
who had both resting energy expenditure and lean body mass measured had similar 
characteristics compared to those invited but who did not undergo these 
measurements. 1NICU denotes neonatal intensive care unit. Term subjects were 
identified from the birth-hospital records for each very low birth weight (VLBW) infant. 
2Only those residing within distance of 110 km were invited. 3Lean body mass was not 
measured, if the subject was pregnant, had foreign object in the body, had severe 
cerebral palsy or was unwilling to undergo the examination. Reprinted with 
permission; the same figure appears in PLoS One. 6(3):e17700. 
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4.1.2 Perinatal and neonatal data 
Perinatal and neonatal data were collected from the hospital records. Gestational age 
was assessed by last menstruation date or by Dubovitz score (Hovi 2011). The infants 
born with VLBW had been weighed daily during their hospital stay. If the weight at 
40 weeks of gestational age was missing from the records, we included the 
interpolated value based on measurements available within 10 days before and 20 
days after this time point in our analysis. We converted the weights into standard 
deviation scores according to Finnish birth weight charts (Pihkala et al. 1989). 
4.1.3 Questionnaire 
The participants completed a detailed questionnaire on medical history, use of 
medication, current smoking, parents’ education (as an indicator of socioeconomic 
status, categorized into four levels according to information on the parent with the 
higher education) and leisure-time physical activity assessed by means of questions 
on exercise intensity (four categories), duration, and frequency (Hovi et al. 2007, 
Kajantie et al. 2010b). 
4.1.4 Clinical examination 
The participants attended a clinical examination at a mean age of 22.5 y (range from 
18.5 to 27.0). It was performed in the clinic at the National Public Health Institute 
(now the National Institute for Health and Welfare) in Helsinki. The participants 
fasted for at least 8 hours (Hovi et al. 2007). When the participant was in underwear, 
nurses measured height and weight and BMI was calculated (weight/height2, kg/m2). 
The nurses used a soft tape to measure waist and hip circumference: waist 
circumference midway between the lowest rib and the iliac crest and hip 
circumference at the level of the great trochanters.  
4.1.5 Resting energy expenditure and lean body mass 
Resting energy expenditure was measured by indirect calorimetry (Deltatrac II, 
Datex, Helsinki, Finland) at rest. Indirect calorimetry is the most commonly used 
method to measure REE, and Deltatrac equipment is well-established as being valid 
and reliable (Tissot et al. 1995, Wells & Fuller 1998, Compher et al. 2006). The 
reproducibility is very good: For example in young (18–35 y) non-lactating 
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Bangladeshi women the mean within-subject within-session variations was 3.0% and 
within-subject between-sessions variation was 4.5% (Alam et al. 2005). The 
measurement was performed after an overnight fast, after the subject had completed 
the consent forms and undergone anthropometric and blood pressure measurements, 
usually approximately 30 minutes after coming to the clinic. The measurement was 
performed by one of the two trained nurses. At first the subject was connected to the 
calorimetry device and rested about 10 minutes before the measurement started. 
During the measurement the subject was wearing light indoor clothing, was still 
fasting and lying in a bed in a comfortable semi-recumbent position and holding a 
transparent plastic canopy, which covers the head of the participant. The device has a 
computerized, open-circuit system to measure gas exchange by the air-dilution 
method. REE was expressed as the amount of energy used in 24 hours (Dulloo & 
Jacquet 1998, Jørgensen et al. 1998, Wang et al. 2000, Eriksson et al. 2002, 
Heymsfield et al. 2002, Johnstone et al. 2005).  
Lean body mass was measured at a separate visit by DXA (Hologic® Discovery 
A, software version 12.3:3, Bedford, MA, USA) (Hovi et al. 2007, Hovi et al. 2009). 
During the measurements the subjects were wearing underwear alone and they were 
not allowed to wear any jewelry and other personal effects that could interfere with 
the DXA measurement. If measurements contained artifacts which could affect the 
accuracy of DXA they were excluded from the analysis. The ratio of REE to LBM 
(REE/LBM) was calculated (Eriksson et al. 2002). Originally DXA was developed 
for diagnosis of osteoporosis, but it also provides detailed and precise information 
about body composition. It is a clinically applicable if not “bedside” method (Mazess 
et al. 1990). It involves measurement of the relative attenuation of two different 
energy X-rays and produces a three-component model of body composition including 
fat, bone mineral, and lean tissue. Scans are relatively fast, with minimal radiation 
exposure (Woodrow 2007). DXA is reliable and reproducible in the estimation of 
LBM, and reproducibility of measurements is excellent, with r value of 0.98 (Lohman 
et al. 2009). However, it does not distinguish between visceral and subcutaneous fat 
tissue (Haarbo et al. 1991, Svendsen et al. 1993, Glickman et al. 2004). 
4.2 Northern Finland Birth Cohort 1986 (II–IV) 
The Northern Finland Birth Cohort 1986 (NFBC 1986) is a prospectively collected 
longitudinal cohort of all births in the two northernmost provinces of Finland, with 
mothers and children whose expected delivery date was between July 1st 1985 and 
June 30th 1986. In total 9 479 children were born into the cohort, and 9 432 of them 
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were live-born. Mothers and children have been followed up since the mothers 
enrolled at their first antenatal clinic visit, usually by the twelfth week of gestation 
(Järvelin et al. 1993a, Pirkola et al. 2008).  
Fig. 7. Participants in the study (article II). 
4.2.1 The study population 
At a mean age of 16 years, 6798 (74%) cohort members residing in Finland 
participated in a clinical examination, which was conducted in 2001–2002 (Fig. 7). In 
our analysis we included those 6642 subjects with data on length of gestation and at 
least one of the following variables: BMI, waist circumference, blood pressure, 
plasma lipids, plasma glucose and serum insulin. In total, 79 (1.2%) of the study 
subjects included in the analysis were born early preterm (<34 weeks), 238 (3.6%) 
were born late preterm (34 to <37 weeks) and 6325 (95.2%) were controls (≥37 
weeks).  
Subjects with insufficient data for analysis had a shorter length of gestation (0.27 
weeks, P<0.001), were more likely to be born preterm (P<0.001), had a lower birth 
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weight (77 g, P<0.001) and a lower birth weight SD score (0.1 SD, P<0.001) and 
were more likely to be born SGA (P=0.006).  
4.2.2 Perinatal and neonatal data 
Perinatal data were collected from healthcare records and questionnaires. The overall 
incidence of preterm deliveries was 4.8%, of which 70.8% were spontaneous preterm 
deliveries (Olsen et al. 1995). We confirmed length of gestation by reviewing original 
hospital records (Vääräsmäki et al. 2009, Miettola et al. 2013). We calculated the 
birth weight SD score on the basis of Finnish standards (Pihkala et al. 1989) and SGA 
was defined as lower than 2 SD below the mean. 
In 1985–1986, when the study subjects were born, routine determination of 
length of gestation by ultrasonography was the practice in a number of towns and 
municipalities in the region, but not in all. The cohort database included data 
indicating length of gestation, which were collected from three sources:  
1. If the length of gestation was estimated or confirmed by ultrasonography 
(before 20 weeks of gestation), it was obtained from maternal welfare clinic 
records.  
2. If ultrasonography was not performed, the length of gestation was estimated 
on the basis of the last menstrual period, and it was collected from maternal 
welfare clinic records.  
3. The length of gestation was based on clinical decision-making and recorded 
in full completed weeks in birth hospital records.  
We looked at these variables and if there was a discrepancy, we reviewed the data 
and medical records if needed.  
The length of gestation was determined by ultrasonography in 3699 (39.2%) 
cases, by last menstrual period in 5358 (56.8%) cases, and according to data in 
hospital records, based on clinical decision-making with no information as to whether 
this was based on ultrasonography or last menstrual period in 154 (1.6%) cases. We 
were unable to confirm the length of gestation in 221 cases (2.3%).  
We categorized the subjects into three groups according to their gestational age: 
1. <34 weeks of gestation (early preterm) 
2. 34 to <37 weeks of gestation (late preterm) (Engle et al. 2007) 
3. ≥37 weeks of gestation (controls). 
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4.2.3 Questionnaire 
At the age of 16 the participants (and their parents) completed questionnaires on 
medical history, medication, socioeconomic status and lifestyle. We used parental 
educational attainment as an indicator of socioeconomic status and it was categorized 
into four levels (dummy coded). Regular smoking (“Have you ever smoked 
regularly?”) was transformed to a dichotomous variable. Physical activity was based 
on questions on daily time spent in commuting and weekly time in light or moderate-
to-vigorous physical activity and transformed to total metabolic equivalent hours per 
week (METh/wk), assuming 3 MET for light activity, 4 MET for commuting, and 5 
MET for moderate-to-vigorous physical activity. The subjects assessed their pubertal 
stage with the help of drawings representing different stages of the Tanner 
classification (Tanner 1962). 
4.2.4 Clinical examination  
At the clinical examination weight (kg), height (cm), waist (cm) and hip 
circumferences (cm)  were measured. Blood pressure was measured from the right arm  
after 15 minutes of rest with the subject sitting, by use of an automated oscillometric 
device (Omron 705CP, Omron Corporation, Shiokoji, Horikawa, Kyoto, Japan) or 
mercury sphygmomanometer if the first one failed. The mean of two measurements 
taken two minutes apart was calculated. 
4.2.5 Laboratory analyses 
Fasting blood samples collected between 8:00 and 11:00 were analyzed within 24 
hours of sampling at Oulu University Hospital laboratory by using a Cobas Integra 
700 automatic analyzer (Roche Diagnostics, Basel, Switzerland): plasma glucose by 
using an enzymatic reference method with hexokinase, TC, HDL-C, LDL-C, and TG 
concentrations with an enzymatic, colorimetric method, and ApoA1 and ApoB with 
an immunoturbidimetric method (Vääräsmäki et al. 2009). Samples for serum insulin 
measurement were stored at -20 °C and analyzed by radioimmunoassay with 
commercial reagents (Pharmacia Diagnostics, Uppsala, Sweden) within 7 days. We 
used homeostasis model assessment values for insulin resistance (HOMA-IR) by 
calculating them from paired fasting glucose and insulin levels by way of the 
validated calculator program available at www.dtu.ox.ac.uk (Wallace et al. 2004).  
 58 
4.3 The ESTER Study (III, IV) 
The ESTER study (“Preterm birth and early life programming of adult health and 
disease” and Maternal pregnancy disorders and child’s health in adulthood) is a birth 
cohort study conducted in 2009 to 2011 in the two northernmost provinces of Finland. 
The study has been carried out as a collaborative effort between the National Institute 
for Health and Welfare, the Institute of Health Science in the University of Oulu, the 
Northern Ostrobothnia Hospital District and the University of Helsinki. The ESTER 
study consists of two sub-studies:  
1. Preterm birth and early life programming of adult health and disease (the 
ESTER Preterm Birth Study), and  
2.  Maternal pregnancy disorders and child’s health in adulthood.  
Subjects born in 1985–1986 were recruited from NFBC 1986 and subjects born in 
1987–1989 from The Finnish Medical Birth Register (FMBR), born in the same 
geographical area. We selected all the subjects from NFBC 1986 who were born 
preterm (<37 weeks of gestation), and those who were exposed to maternal 
hypertension, preeclampsia or diabetes. In addition, we selected subjects 
randomly from the FMBR with same criteria. Control group subjects were 
selected randomly from both NFBC 1986 and FMBR. The total number of 
subjects who attended the examination is 1161.  
4.3.1 The study population  
The present work is focused on the effects of preterm birth on cardiovascular risk 
factors, so we included those born preterm and their randomly selected controls.  
Subjects were categorized into three groups according to their gestational age:  
1. <34 weeks of gestation (early preterm, n=149), 
2. 34 to <37 weeks of gestation (late preterm, n=248) (Engle et al. 2007), and  
3. ≥37 weeks (controls, n=380). The control group also includes 16 subjects 
technically born post-term (at 42 weeks 1 day or later). 
The selection of the subjects included in the analysis is presented in Fig. 8 (for article 
III) and Fig. 9 (for article IV). 
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Fig. 8. Flow chart of the study population (article III). All subjects recruited to the study 
are born in Northern Finland in 1986-1989. In the Finnish Medical Birth Register data 
83 individuals in the random control group with missing gestational age of whop 58 
individuals did not participate and 25 participated to the ESTER study. 10 subjects 
born early preterm, 1 subject born late preterm and 4 controls reported severe 
disability and were excluded from the analysis. 5 subject born early preterm, 5 
subjects born late preterm and 8 controls reported being pregnant and were excluded 
from the analysis. 3 excluded subjects had more than one reason for exclusion. 
Abbreviations: FMBR, Finnish Medical Birth Register; NFBC, Northern Finland Birth 
Cohort. Printed with permission; the same figure appears in Am J Epidemiol 2015: In 
press. 
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4.3.2 Perinatal and neonatal data 
Perinatal data on members of the NFBC 1986 were collected as described previously 
in section 4.2.2 (Järvelin et al. 1993b). We collected similar peri- and neonatal 
variables concerning FMBR subjects from the patient records of hospitals and 
maternal welfare clinics. We determined the length of gestation of NFBC and FMBR 
subjects as described above (section 4.2.2). We recorded diagnoses of maternal 
gestational diabetes, hypertension (gestational or chronic) and preeclampsia 
(including superimposed) retrospectively according to prevailing medical guidelines. 
The birth weight SD score was calculated according to Finnish standards (Pihkala et 
al. 1989) and SGA was defined as lower than 2 SD below the mean. 
4.3.3 Questionnaire 
The participants completed questionnaires before the clinical visit electronically or 
during or after the visit on paper. The questionnaire included questions about medical 
history and medication including hormonal contraception, socioeconomic status and 
lifestyle. We used parental educational attainment as an indicator of socioeconomic 
status and it was categorized and dummy-coded (four levels). Physical activity was 
assessed as described above (section 4.2.3). Daily smoking (yes/no) and the amount 
of alcohol doses per week (0; 1 to 3; 4 to 9; ≥10) were categorized. 
4.3.4 Clinical examination 
The subjects participated in clinical examination at clinics in Oulu, Kemi, Kuusamo, 
Raahe, Rovaniemi and Ylivieska. The participants had fasted overnight before the 
clinical visit.With the subject in a sitting position and after five minutes’ rest, a 
trained study nurse measured blood pressure (mm Hg) from the upper right arm, using 
an automatic oscillometric blood pressure monitor (Intellisense M10-IT, cuff size 22–
42 cm; Omron Healthcare Co., Ltd., Kyoto, Japan). Three measurements were taken 
and the mean was calculated. Height (cm) was measured three times; waist 
circumference (cm, midway between the lowest rib and the iliac crest) and hip 
circumference (cm, at the widest point of the hip) were measured twice. Using the 
means of repeated measurements, BMI and the waist-hip ratio (WHR=waist 
circumference/hip circumference) were calculated. We measured body composition 
(weight, plus lean body mass, fat mass and percentage body fat) by segmental multi-
frequency bioelectrical impedance analysis (BIA; InBody 3.0, Biospace Co., Ltd., 
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Seoul, Korea). It is based on the principle that lean mass, which is primarily an 
electrolyte solution, conducts current better than fat mass. The method gives a 
measure of the resistance to a weak current (impedance) applied across extremities 
and provides an estimate of body fat using an empirically derived equation. BIA has 
been shown to give accurate estimates of body components in different populations 
with high reliability in repeated measurements (Bedogni et al. 2002, Malavolti et al. 
2003, Sartorio et al. 2005, Gibson et al. 2008) and is practical in large 
epidemiological studies . Correlations between BIA and DXA as regards percentage 
body fat are generally good (Bolanowski & Nilsson 2001), but BIA tends to 
overestimate percentage body fat in lean subjects and underestimates it in obese 
subjects (Sun et al. 2005). 
4.3.5 Laboratory analyses 
The subjects fasted overnight and blood samples were collected at 8:00–11:00 a.m. 
and 2 hours after a 75-gram oral glucose load. Some of the analyses were performed 
at Oulu University Hospital laboratory: Plasma glucose (fasting and 2-hour), TC, 
HDL-C and LDL-C, TG, uric acid, alanine aminotransferase, aspartate 
aminotransferase, gamma glutamate, albumin and urea were analyzed by using an 
Advia 2400 automatic chemical analyzer (Siemens Diagnostics, Terrytown, NY, 
USA) and blood leukocytes by an automatic electronic cell counter (Abbott CELL-
DYN Sapphire, Abbott Diagnostics, USA).  
Remaining samples were stored at -70 ºC. Other analyses were performed later at 
the Disease Risk Unit of the National Institute for Health and Welfare: Serum 
concentrations of insulin, lipoprotein (a) (LPa), ApoA1, ApoB, and hsCRP (values 
>10 mg/l were excluded from analysis) were measured by using an Architect ci8200 
analyzer (Abbott Laboratories, USA). The following methods were used: 
chemiluminescent microparticle immunoassay (CMIA, Abbott Laboratories, USA) 
for insulin, immunoturbidimetric methods (Abbott Laboratories, USA) for LPa, 
ApoA1 and ApoB and a latex immunoassay (Sentinel Diagnostics, Italy) for hsCRP. 
HOMA-IR values from paired fasting glucose and insulin levels were defined by 
using a validated calculator program available at www.dtu.ox.ac.uk (Wallace et al. 
2004). 
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4.3.6 Ambulatory measurements 
To measure 24-hour blood pressure, volunteer subjects were given ambulatory blood 
pressure (ABP) monitors with operating instructions (Spacelabs 90207, Spacelabs 
Medical, Inc., WA, U.S.A.) after the clinical examination, if there were available 
devices. The subjects wore the cuff on the non-dominant upper arm and carried the 
device for 24 hours. The monitors measured their blood pressure every 20 minutes 
during the day (7:00 to 22:00 h) and every 30 minutes at night (22:00 to 7:00 h).  
Thirty-two (76.2%) subjects born early preterm, 47 (65.3%) subjects born late 
preterm and 78 (75.7%) controls agreed to wear an accelerometer (GT1M; ActiGraph, 
Inc., Pensacola, FL) on the wrist to measure the sleep–wake rhythm simultaneously 
with the ABP monitor (Fig.9). They were instructed to keep a sleep log reporting their 
bedtimes and wake-up times. After the measurements, the participants returned the 
devices to the researchers for data download. We visually inspected the accuracy of 
the sleep log against the raw accelerometry data. We removed the night-time data 
with inconsistent (e.g., the participant was already sleeping at the reported bedtime) or 
missing information on bedtimes. If the reported wake-up time was inconsistent (e.g., 
the participant was still asleep after the reported wake-up time) or missing, it was 
visually estimated from the raw accelerometry data. Sleep onset time was estimated 
by using ActiLife software (ActiLife 5.10.0; ActiGraph Pensacola, FL, USA), with 
the Sadeh algorithm (Sadeh et al. 1994). For the 60 (27.6%) subjects who had no 
accelerometry data, BP when sleep was defined as that between 01:00 and 07:00 h, 
and BP when awake was defined as that between 09:00 and 23:00 h. In other words, 
we excluded measurements taken between 07:00 and 09:00 h and between 23:00 and 
01:00 h, because of the potential individual variability in bedtimes and wake-up 
times.  
We excluded from the analysis subjects with fewer than 15 BP measurements 
when awake or fewer than eight BP measurements when asleep (O'Brien et al. 2000) 
and these subjects were also excluded from 24-hour BP analysis. We calculated the 
means of the subjects’ 24-hour, awake and asleep ABPs (mmHg) and SDs of BP 
(mmHg, indicators of individual BP variability). 
4.3.7 Definitions of pre-hypertension, hypertension, fatty liver index, 
obesity and metabolic syndrome 
The cut-off values of office-measured, ambulatory-measured and white-coat 
hypertension are presented in Table 8. The definition of office-measured hypertension  
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Fig. 9. Flowchart of the study population (article IV). Printed with permission; the 
same figure appears in Hypertension 2015;65: 615-621. 
was based on the criteria of the European Society of Hypertension (ESH), the 
European Society of Cardiology (ESC) and the American Heart Association 
(Pickering et al. 2005, Mancia et al. 2013). We defined abnormal mean values of 
ABP and white-coat hypertension according to criteria of the American Heart 
Association and the British Hypertension Society (O'Brien et al. 2000, Urbina et al. 
2008). We calculated the fall (or “dip”, %) of mean blood pressure from awake to 
sleep blood pressure as: (mean awake blood pressure - mean sleep blood 
pressure)/mean awake blood pressure * 100 (Verdecchia et al. 1994). If blood 
pressure when asleep was less than 10% lower than when awake, the subject was 
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categorized as a “non-dipper” (Verdecchia et al. 1994). We defined the metabolic 
syndrome according to the Joint Interim Statement (Table 8) (Alberti et al. 2009).  
We calculated the fatty liver index (FLI), a proposed marker of non-alcoholic 
fatty liver disease (Bedogni et al. 2006) as:  
 
ܨܮܫ =  ௘బ.వఱయ×೗೙ (೅ಸ) శ బ.భయవ×ಳಾ಺ శ బ.ళభఴ×೗೙ (ಸಸ೅) శ బ.బఱయ×ೈ಴ ష భఱ.ళరఱଵ ା ௘బ.వఱయ×೗೙ (೅ಸ) శ బ.భయవ×ಳಾ಺ శ బ.ళభఴ×೗೙ (ಸಸ೅) శ బ.బఱయ×ೈ಴ ష భఱ.ళరఱ × 100  
 
Abbreviations (units) in equation: 
TG, triglycerides (mg/dl); 1 mg/ml = 18.0182 mmol/l 
BMI, body mass index (kg/m2) 
GGT, gamma glutamate (U/l) 
WC, waist circumference (cm) 
 
An FLI value of <30 rules out hepatic steatosis with 87% sensitivity and a 
negative likelihood ratio of 0.2 and a value of ≥60 rules out hepatic steatosis with 
86% sensitivity and a positive likelihood ratio of 4.3 (Bedogni et al. 2006). We 
used an FLI value of >30 as a marker of intermediate or high FLI.  
4.3.8 Subjects included in the analysis and the attrition analyses  
We excluded those who were pregnant (n=21) or who reported having cerebral palsy 
(n=8), mental disability (n=11) and/or several physical disability (n=5) from the 
analysis of cardiometabolic risk factors (publication III), because these conditions 
might have an effect on cardiometabolic risk factors. Finally, we had sufficient data 
on cardiometabolic risk factors among 134 individuals born early preterm, 242 born 
late preterm, and 344 controls who were born at term.  
We compared those who participated with those who did not participate or who 
were excluded from the analysis. In the late-preterm group and in the controls, women 
were more likely to participate. In addition, among the late-preterm adults, those who 
participated were more likely to be born to primiparous mothers. The participants and 
non-participants did not differ as regards mothers’ age at birth, maternal hypertension 
in pregnancy, maternal smoking, maternity hospital, length of gestation, birth weight 
or birth weight SD score. We looked at the clinical data at 16 years of age among the 
NFBC 1986 members. Those who participated in this study were more likely to have  
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Table 8. Definitions and cut-off values for hypertension, obesity and metabolic 
syndrome. 
Definition Cut-off values 
Pre-hypertension ≥120/80 mmHg 
Hypertension (office-measured) ≥140/90 mmHg 
  
Abnormal ambulatory blood pressure  
24-hour  >135/85 mmHg 
Awake >140/90 mmHg 
Sleep >125/75 mmHg 
  
White-coat hypertension Both of the following criteria: 
Office blood pressure ≥140/90 mmHg 
Day-time ambulatory BP <135/85 mmHg  
  
Obesity  
Body mass index >30 kg/m2 
  
Metabolic syndrome 3 of the 5 following criteria: 
Waist circumference ≥94 cm in men; ≥80 cm in women 
Triglycerides ≥1.7 mmol/l 
HDL-C  <1.03 mmol/l in men;   
<1.29 mmol in women 
Blood pressure ≥130/85 mm Hg 
Fasting plasma glucose ≥5.6 mmol/l or type 2 diabetes 
participated in clinical examination at 16 years, but the participants and non-
participants did not differ as regards BMI and parental educational attainment, 
and the rates of physical and mental disability were similar within the groups.  
Not all the participants wanted to wear an ABP monitor after the clinical visit, or 
ABP data were missing for some other reason. We also excluded five pregnant 
subjects (one early preterm, two late preterm, and two controls) and two controls who 
were taking beta-blocker medication from the ABP analysis. Altogether, we had 
sufficient data on ambulatory blood pressure measurements on 42 (28.2%) 
participants in the early-preterm group, 72 (29.0%) participants in the late-preterm 
group and 103 (28.9%) controls (P=0.98). The proportion of subjects with sufficient 
ABP data was similar in every group. Women were more likely to have sufficient 
ABP data than men in the control and early-preterm groups. The subjects invited to 
the ESTER study who did not participate or who did not have sufficient ABP data 
were more likely to have been exposed to maternal smoking during pregnancy 
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(P=0.04). Participants with and without sufficient ABP data were of similar age and 
had similar parental educational attainment, BMI and office-measured BP. In the 
early-preterm group and in controls, those without sufficient data were more likely to 
smoke, and in the early-preterm group men without sufficient data were 3.1 cm 
shorter than those with ABP data (P=0.02). To control for possible differences in 
blood pressure levels in those without accelerometry we adjusted the mean 
differences in ABP outcomes for use of an accelerometer. 
4.4 Statistical methods 
We performed statistical analyses with SPSS for Windows software, versions 16.0 
(SPSS Inc., Chicago, Illinois) to 22.0 (IBM SPSS Statistics Version 22, USA). We 
used logarithmic transformation to normalize skewed distributions to achieve 
normality of all outcome variables except blood pressure, height and concentrations 
of uric acid, albumin and urea. We also calculated the geometric means of those 
variables which are the nth roots of the product of n values. Geometric standard 
deviation corresponds to the relative change in a variable corresponding to one 
standard deviation unit change in the logarithm of the variable. We assessed group 
differences in background characteristics by using Student’s t test for continuous data 
and Pearson’s χ2 test for categorical data. To assess differences between preterm 
(VLBW/early-preterm/late-preterm) subjects and controls we used linear or logistic 
regression models to adjust for covariates described in Fig. 10 and Table 9:  
Covariates in linear regression models assessing the association between preterm 
birth vs. REE and the REE/LBM ratio in adults born preterm with VLBW (I): 
– Model 1: Age and sex. 
– Model 2: Variables in Model 1and parental education and daily smoking. 
– Model 3: Variables in Model 2 and body fat percentage and self-reported 
intensity, frequency and duration of leisure-time physical activity. 
Covariates in linear regression models assessing cardiovascular risk factors in 
adolescents born preterm (II): 
– Model 0: Unadjusted. 
– Model 1: Age. 
– Model 2: Variables in Model 1 and BMI and height. 
– Model 3: Variables in Model 2 and birth weight SD score, maternal smoking 
during pregnancy, and educational level of more educated parent.  
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– Model 4: Variables in Model 3 and smoking, physical activity and Tanner 
pubertal stage. 
Covariates in linear regression models assessing cardiometabolic risk factors in 
adults born preterm (III): 
– Model 1: Age, cohort (NFBC or FMBR), and sex.  
–  Model 2: Variables in Model 1 and parental and prenatal confounding factors 
(including parental educational attainment as a proxy of childhood 
socioeconomic position, maternal smoking during pregnancy, and birth 
weight SD scores as indicators of fetal conditions during pregnancy), and, for 
analyses of dichotomous and biochemical outcomes, parental history of 
hypertension, diabetes, and myocardial infarction or stroke as proxies of 
genetic susceptibility.  
– Model 3: Variables in Model 1 and current characteristics: height (for body 
composition and blood pressure) or BMI (for blood pressure and biochemical 
risk factors), physical activity, and smoking. For fatty liver index, these 
adjustments also included current alcohol use.  
– Model 4: variables in Models 2 and 3. 
Covariates in linear regression models assessing ambulatory blood pressure and 
its variability in adults born preterm (IV): 
– Model 1: Age and sex. In addition, models for BP when awake and sleep also 
included whether sleep was assessed by accelerometry.  
– Model 2: Variables in Model 1 and parental educational level, mother’s BMI 
before pregnancy, gestational or chronic hypertension, preeclampsia, GDM, 
and birth weight SD score.  
– Model 3: Model 1 and parental educational attainment, height, BMI, physical 
activity, and smoking. 
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Fig. 10. Causal diagram (or direct acyclic graph) for the linear and logistic regression 
models (Textor et al. 2011).  
In addition, we reported some of the analyses with length of gestation as a 
continuous variable. We tested whether the associations between preterm birth 
and outcomes were similar in men and women by adding the interaction terms 
sex*VLBW or sex*early preterm birth or sex*late preterm birth to the model. All 
P-values were 2-sided. 
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5 Results  
The perinatal and neonatal characteristics of the study groups are presented in Table 
11. In every cohort, subjects born preterm were more likely to be exposed to 
preeclampsia of the mother, born from multiple pregnancy and be SGA, as expected. 
To summarize the current findings, the results of each outcome variable group are 
presented together. 
5.1 Body size and composition (I, II, III) 
5.1.1 Body size and composition in adults born preterm with VLBW (I) 
Differences in body size and composition in adults born preterm compared with their 
peers born at term (HeSVA) have been published before and are presented in the 
Review of the literature (section 2.4.1). In short, adults born preterm with VLBW 
were shorter and lighter and had lower lean body mass than their peers born at term 
(Table 10).  
Table 10. Mean values (SD) of lean body mass in women and men born with VLBW 
and in controls born at term. 
Measurement Women Men 
VLBW Term P value VLBW Term P value 
Height (cm) 162.4 (8.0) 167.6 (6.3) <0.001 175.9 (8.5) 180.7 (6.1) 0.003 
BMI 21.8 (3.7) 23.0 (3.9) 0.064 22.1 (4.0) 23.9 (3.2) 0.020 
Body fat percentage (%) 31.9 (6.2) 32.0 (5.6) 0.92 19.9 (6.4) 19.9 (5.4) 0.97 
Lean body mass (kg) 38.9 (5.9) 43.5 (5.5) <0.001 54.4 (8.9) 62.2 (8.4) <0.001 
5.1.2 Body size in adolescents born preterm in NFBC (II) 
In NFBC, adolescent girls and boys born preterm had similar weight, height, BMI, 
waist and hip circumference as their peers born at term (Table 12), even when 
adjusted for SD for birth weight, age, parental education, smoking and physical 
activity, and Tanner Pubertal Stage. 
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Table 12. Mean (SD) in body sizes of girls and boys born early and late preterm, and 
controls born at term. 
Measurement Sex Early preterm Late preterm Controls 
Mean (SD) P value Mean (SD) P value Mean (SD) 
Height (cm) Girls 163.6 (6.3) 0.90 163.6 (5.3) 0.73 163.9 (6.0) 
 Boys 174.7 (7.9) 0.70 174.6 (7.1) 0.56 174.8 (6.8) 
Body mass index (kg/m2) Girls 20.9 (1.2) 0.25 20.9 (1.2) 0.53 21.0 (1.2) 
 Boys 20.2 (1.1) 0.85 20.9 (1.2) 0.95 20.9 (1.2) 
Waist circumference (cm) Girls 72.2 (1.1) 0.45 71.6 (1.1) 0.39 71.5 (1.1) 
 Boys 74.3 (1.1) 0.58 75.8 (1.1) 0.91 75.3 (1.1) 
5.1.3 Body size and composition of young adults born preterm (III) 
In the ESTER study, adults born early and late preterm had similar heights as their 
peers born at term (Table 13.Fig. 11). However, when adjusted for confounders in 
order to assess the total effect (sex, age, cohort, parental education, maternal smoking 
during pregnancy, birth weight SD score) and direct effect (in addition to the 
covariates in the total effect model, for height, physical activity, daily smoking) of 
preterm birth, they were taller than the controls. Adults born early preterm also had 
similar BMIs and LBMs as their peers born at term. However, they had higher waist 
circumferences, waist-hip ratios, fat mass and body fat percentages (Table 13), but the 
difference in fat mass was statistically significant in the model assessing the direct 
effect of preterm birth on adult body composition. Adults born late preterm had 
higher BMIs, waist circumferences, waist-hip ratios, fat mass and percentage body fat 
(Table 13.Fig. 11). The differences remained similar when controlled for the 
covariates. They also had higher LBMs, but the difference [3.6% (1.4, 5.8)] was 
statistically significant only in the model assessing the total effect of preterm birth on 
adult body composition. Adults born early and late preterm were about 2-fold more 
likely to be obese than the controls: OR 2.2 (95% CI 1.1, 4.1) for early preterm and 
OR 1.7 (95% CI 1.0, 3.1) for late preterm group when adjusted for age, sex and 
source cohort (Table 22.Fig. 16). 
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Fig. 11. Mean percentage differences (except for height in cm) and 95% confidence 
intervals (error bars) in body size and composition in adults born early and late 
preterm compared with controls (zero line), adjusted for age, sex and cohort (whether 
they are recruited from the Northern Finland Birth Cohort or the Finnish Medical Birth 
Register). 
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To study whether or not perinatal conditions that may accompany preterm birth 
contributed to later body size and composition, we reanalyzed the data by 1) 
excluding those born SGA, 2) excluding those born after multiple pregnancy, and 
3) adjusting the analyses for maternal gestational diabetes. This did not alter any 
of the conclusions. We further adjusted the analyses for maternal hypertension in 
pregnancy, and the differences in fat mass and body fat percentage attenuated the 
differences among those born early preterm.  
Further, we compared those born SGA to those born AGA within the preterm 
groups. Adults born early preterm and SGA (EPT-SGA) were 4.0 cm (95% CI 1.2, 
6.8) shorter and had 9.3% (95% CI 3.1, 15.2) lower LBM than adults born early 
preterm and AGA (EPT-AGA) when adjusted for age, sex and cohort. Adults born 
late preterm and SGA (LPT-SGA) were 4.9 cm (05% CI 2.6, 9.2) shorter and had 
9.4% (95% CI 5.1, 13.7) lower LBM than adults born late preterm and AGA (LPT-
AGA). However, we found no statistically significant difference in BMI, waist 
circumference, fat mass, or percentage body fat between SGA and AGA subjects in 
early and preterm groups. 
5.2 Resting energy expenditure (I) 
We found that adults born preterm with VLBW had 6.3% (95% CI 3.2, 9.3) lower 
REE, but 6.1% (95% CI 3.4, 8.6) higher REE per unit lean body mass (REE/LBM 
ratio) compared with peers born at term when adjusted for age and sex (Table 14, 
HeSVA). The differences in REE and the REE/LBM ratio were little affected after 
adjustment for age, sex, parental education, daily smoking, body fat percentage and 
the intensity, frequency and duration of self-reported leisure time physical activity. 
The interaction between VLBW and sex on these outcomes was not statistically 
significant (all P values >0.27), meaning that the association between preterm birth 
with VLBW on REE and the REE/LBM ratio was similar in women and men. 
Therefore we presented the results pooled for both sexes.  
We carried out additional analyses to examine the effects of perinatal and other 
clinical characteristics on energy metabolism. We reanalyzed the data after exclusion 
of subjects a) born from multiple pregnancies, b) subjects with cerebral palsy, 
developmental delay, or severe sensorineural deficit, or c) with regular usage of beta-
sympathomimetic drugs. The results were similar. 
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Table 14. Mean (SD) resting energy expenditure (REE) and resting energy expenditure 
per unit lean body mass (REE/LBM ratio) in women and men born preterm with very 
low birth weight (VLBW) and controls born at term, and mean percentage differences 
in percent (95% CIs) between adults born with VLBW vs. controls. 
Measurement VLBW; mean (SD) Term; mean (SD) Mean difference  
(95% CI) Women Men Women Men 
REE (kcal/24h) 1442 (207) 1834 (253) 1520 (172) 1977 (237) -6.3%  
(-10.4 to -2.0) 
REE/LBM ratio (kcal/24h/kg) 37.4 (4.4) 33.9 (2.6) 35.1 (3.0) 31.9 (2.3) 6.2%  
(3.5 to 9.0) 
Further, we carried out additional subgroup analysis within the VLBW group. 
Subjects born SGA (n=25) had a 6.2% (95% CI 0.15%, 11.5%) lower REE, but a 
similar REE/LBM ratio as those born AGA (n=91) when adjusted for age and sex. 
The difference in REE was attenuated after further adjustment for other 
covariates. Within the VLBW group, individuals whose mothers had preeclampsia 
during pregnancy, as compared with those whose mothers did not, had similar 
REE values and similar REE/LBM ratios. In VLBW subjects a one SD unit 
higher score in body weight at what would have been term (40 weeks of 
postmenstrual age) corresponded to a 3.3% (95% CI 0.6%, 6.1%) increase in REE 
and was not related to the REE/LBM ratio. However, the change in SD score 
from birth to term was not related to REE or the REE/LBM ratio. 
5.3 Blood pressure (II–IV) 
The association between preterm birth and blood pressure in adolescence or adulthood 
was reported in three articles: office-measured BP in Articles II and III and 
ambulatory BP in Article IV. 
5.3.1 Blood pressure in adolescents born preterm (II) 
In NFBC 1986 we found statistically significant interactions between the associations 
of early preterm birth and sex on SBP levels (P=0.009) meaning the association of 
preterm birth on blood pressure in adolescence. Therefore we performed analyses 
separately in boys and girls.  
Girls born early preterm had higher SBP higher DBP than control girls (Table 15, 
Fig. 12). The difference remained after adjusting for BMI, height, birth weight SD 
score, maternal smoking during pregnancy, educational level of the more educated 
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parent, smoking of the subject, physical activity, and Tanner Pubertal Stage (full 
model). However, we found no statistically significant difference in BP in girls born 
late preterm compared with girls born at term. In addition, the difference in BP was 
not statistically significant in boys born preterm (early or late) compared with 
controls.  
The association between length of gestation and blood pressure was inverse in 
adolescent girls: a one-week greater length of gestation corresponded to 0.5 mmHg 
(95% CI 0.3, 0.8) lower SBP and 0.2 mmHg (95% CI 0.0, 0.3) lower DBP. However, 
this association was not seen in boys. We found no quadratic relationship between the 
length of gestation and BP in either sex (all P >0.1). 
Table 15. Means (SD) of systolic and diastolic blood pressure (SBP and DBP) in 
adolescent girls and boys born early and late preterm, and controls born at term and 
mean differences (95% CI) between preterm groups and controls adjusted for age. 
Measurement Early preterm Late preterm  Controls 
Mean (SD) Mean difference  
(95% CI) 
Mean (SD) Mean difference  
(95% CI) 
 Mean SD 
Girls       
SBP (mmHg) 116.7 (9.5) 6.7 (3.2, 10.2)  111.8 (10.4) 1.7 (-0.6, 3.9)  109.9 (10.7) 
DBP (mmHg) 70.3 (6.7) 3.5 (1.1, 5.8) 67.6 (6.7) 0.6 (-0.9, 2.1)  66.8 (7.2) 
Boys       
SBP (mmHg) 121.6 (15.4) 0.8 (-7.5, 5.8) 122.6 (14.1) 1.3 (-1.4, 3.5)  121.0 (12.1) 
DBP (mmHg) 68.9 (9.2) -0.1 (-3.6, 3.4) 68.4 (8.2) -0.4 (-1.9, 1.2)  68.6 (7.9) 
However, girls born EPT-SGA had 8.4 mmHg (95% CI 1.5, 15.4) lower SBP and 
4.9 mmHg (95% CI 0.0, 9.7) lower DBP than girls born EPT-AGA. Girls born 
LPT-SGA did not have statistically significant difference in blood pressure when 
compared to girls born LPT-AGA. In addition, no statistically significant 
difference was found in boys born EPT-SGA vs. EPT-AGA or in boys born LPT-
SGA vs LPT-AGA. We further reran the comparisons after excluding those born 
SGA from preterm and control groups and the difference in BP was even greater 
in girls born early preterm compared with controls. The results were similar when 
subjects exposed to maternal GDM or maternal hypertensive pregnancy disorders 
were excluded. 
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5.3.2 Blood pressure in young adults born preterm (III) 
In the ESTER study adults born early preterm had higher SBP and DBP than the 
controls (Table 16). The difference remained statistically significant when further 
adjusted for  
1. age, sex, cohort, height, BMI, parental educational attainment, maternal 
smoking during pregnancy, parent’s history of hypertension, diabetes, and 
coronary heart disease or stroke, and birth weight SD score (total effect) 
2. age, sex, cohort, height, BMI, self-reported physical activity and daily 
smoking to control the bias caused by possible intermediate factors 
3. total effect and intermediate factors (direct effect). 
The interaction between preterm birth and sex on BP was not statistically 
significant. For this reason we carried out the analysis simultaneously for women 
and men. 
We further adjusted the analyses for maternal hypertension in pregnancy. 
Subjects exposed to maternal hypertension had 3.6 mm Hg higher systolic and 2.7 
mm Hg higher diastolic blood pressure compared with those not exposed (adjusted for 
the direct effect model). When adjusted for maternal hypertension, the differences in 
systolic/diastolic blood pressures vs. those in the controls became attenuated to 1.9 
(95% CI -0.3, 4.0)/1.7 mmHg (0.1, 3.3) for early preterm and 0.5 mmHg (-1.2, 
2.3)/0.02 mmHg (-1.1, 1.6) for late preterm infants. However, the results remained 
similar when we reran the analysis excluding those born SGA or born from multiple 
pregnancy or those exposed to maternal GDM. We also compared those born SGA to 
those born AGA within the early and late preterm groups and there were no 
statistically significant difference in systolic or diastolic blood pressure.  
Table 16. Mean systolic and diastolic blood pressures (SBP and DBP) in adults born 
early and late preterm compared with controls born at term, and mean differences 
(95% CI) between preterm groups and controls adjusted for age, sex and cohort 
(NFBC or FMBR). 
Measurement Early preterm Late preterm Controls 
Mean (SD) Mean difference  
(95% CI) 
Mean (SD) Mean difference  
(95% CI) 
Mean (SD) 
SBP (mmHg) 118.9 (12.9) 3.0 (0.9, 5.1) 117.7 (13.4) 1.7 (-0.1, 3.4) 116.3 (12.7) 
DBP (mmHg) 77.8 (8.9) 2.6 (0.9, 4.2) 76.5 (8.2) 1.2 (-0.1, 2.5) 75.5 (7.6) 
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5.3.3 Ambulatory blood pressure in young adults born preterm (IV) 
In the ESTER study, adults born early preterm had higher 24-hour SBP and DBP, 
higher SBP and DBP when awake and higher DBP when asleep versus controls when 
adjusted for age, sex and use of an accelerometer (Table 17). The difference in 24-
hour and awake SBP remained similar when further adjusted for covariates (parental 
educational level, mother’s BMI before pregnancy, gestational or chronic 
hypertension, preeclampsia [including superimposed preeclampsia], gestational 
diabetes, birth weight SD score, height, BMI, physical activity and daily smoking). 
However, the differences in 24-hour DBP, and awake DBP and sleep SBP were not 
statistically significant when controlled for perinatal factors (parental educational 
level, mother’s BMI before pregnancy, gestational or chronic hypertension, 
preeclampsia gestational diabetes and birth weight SD score). Adults born late 
preterm had no statistically significant difference in mean ABP (0). A one-week 
increase in the length of gestation was associated with approximately 0.6 mmHg (0.1, 
1.0) lower 24-hour and awake SBP and 0.3 mmHg (0.04, 0.6) lower 24-hour DBP and 
0.4 mmHg (0.1, 0.7) lower awake DBP. However, no statistically significant 
association between length of gestation and sleep SBP or DBP was found. 
We found no statistically significant interactions between the associations of 
early or late preterm birth and sex on ambulatory blood pressure levels (P≥0.08), 
except for awake SBP among late preterm (P=0.05). However, we further performed 
analyses separately in women and men. Differences between adults born early 
preterm and controls were seen in both sexes in awake SBP. In addition. women born 
early preterm had higher 24-hour DBP and awake DBP  than controls. However, men 
born early preterm had higher 24-hour SBP than controls. Differences between adults 
born late preterm and controls were seen only among men: men born late preterm had 
higher 24-hour SBP and DBP than men born at term.  
Maternal chronic and gestational hypertension during pregnancy was 
independently associated with higher ABP, while maternal preeclampsia was not. 
Therefore, we reanalyzed the data after excluding subjects exposed to maternal 
hypertension during pregnancy, and the difference between adults born early preterm 
and controls in 24-hour SBP attenuated to 5.4 mm Hg (95% CI 1.6, 9.2). Otherwise, 
the differences remained similar. When subjects born with SGA were excluded from 
the analyses, the differences in mean ABP between the early preterm and control 
groups increased by 0.1–0.5 mm Hg, 
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Variability of ambulatory blood pressure 
Adults born early preterm also had higher SDs of 24-hour SBP and DBP, SD of 
awake SBP and DBP and SD of sleep DBP (Table 17). The differences were similar 
when adjusted for covariates (parental educational level, mother’s BMI before 
pregnancy, gestational or chronic hypertension, preeclampsia [including 
superimposed preeclampsia], gestational diabetes, birth weight SD score, height, 
BMI, physical activity and daily smoking), except for the SD of wake DBP adjusted 
for perinatal factors (parental educational level, mother’s BMI before pregnancy, 
gestational or chronic hypertension, preeclampsia, gestational diabetes and birth 
weight SD score). Adults born late preterm had 0.8 mmHg (0.1, 1.4) higher SD of 24-
hour DBP, 0.8 mmHg (0.0, 1.6) higher sleep SBP and 0.6 mmHg (-0.2, 1.4) higher 
SD of sleep DBP when adjusted for age, sex and use of an accelerometer (Table 17). 
Otherwise, no statistically significant difference in SD of ambulatory blood pressure 
was found between the late preterm group and controls. A one-week increase in the 
length of gestation was associated with approximately 0.1–0.2 mmHg lower SD of 
24-hour SBP and DBP, SBP and DBP and sleep DBP. We reanalyzed the data after 
excluding subjects exposed to maternal hypertension during pregnancy, and the 
differences in SDs of ABP remained similar. We further reran the analyses after 
excluding subjects born SGA. The differences in the SDs of ABP attenuated by up to 
0.2 mm Hg. 
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Fig. 12. The mean difference and 95% confidence intervals (error bars) in office and 
ambulatory measured blood pressure in adolescents and adults born early preterm 
compared to controls (zero line) adjusted for age (and sex and cohort). 
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Fig. 13. The mean difference and 95% confidence intervals (error bars) in office and 
ambulatory measured blood pressure in adolescents and adults born late preterm 
compared to controls (zero line) adjusted for age (and sex and cohort). 
 87 
5.3.4 Hypertension (II, III) 
In the NFBC 1986 study we did not observe a pronounced risk of hypertension in 
adolescents born preterm, but pre-hypertension was more common in the early 
preterm group (17.7%) than in the controls (9.6%) (P<0.01). However, in the ESTER 
study, adults born preterm were about two- to threefold more likely to have 
hypertension, but the OR was statistically significant only in the early preterm group 
(Table 22.Fig. 16): OR for the early preterm group 2.7 (95% CI 1.3, 5.3) and for the 
late preterm group 1.7 (0.9, 3.2) adjusted for age, sex and cohort. In addition, adults 
born early preterm were more likely to have hypertensive ABP when awake: OR 3.8 
(95% CI 1.1, 13.7). However, the OR was not statistically significant when adjusted 
for other covariates (age, sex, use of an accelerometer, parental educational level, 
mother’s BMI before pregnancy, gestational or chronic hypertension, preeclampsia 
[including superimposed preeclampsia], birth weight SD score, height, BMI, physical 
activity and smoking). 
5.4 Lipid metabolism (II, III) 
The association between preterm birth and lipid profile in adolescence or adulthood 
was different in women and men, so we performed analyses separately for both sexes. 
In the adolescents the P value for interaction between early preterm birth and sex was 
0.02 for LDL-C and it was 0.03 for ApoB. In addition, the P values for the interaction 
terms sex and early preterm birth were 0.035 for HDL-C and 0.019 for ApoA1 (when 
adjusted for age and sex). 
5.4.1 Lipid profile of adolescents born preterm (II) 
Among girls in NFBC, the lipid profiles were similar in all study groups. As for boys, 
those born early preterm had higher mean TC, LDL-C, ApoB and TG levels than 
controls when adjusted for age (Table 18). The differences remained similar when 
controlled for covariates (age, BMI, birth weight SD score, maternal smoking during 
pregnancy, parental education, smoking of the subject, physical activity and pubertal 
stage), except for the TGs when adjusted for current lifestyle factors. Boys born late 
preterm also had higher levels of TGs (Table 18), and when controlled for covariates 
as well. Levels of HDL-C and ApoA1 were similar in boys born early/late preterm 
and controls. In addition, among boys, a one-week greater length of gestation 
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corresponded to 0.5% (95% CI 0.1, 0.9%) lower TC, 1.0% (0.4, 1.6%) lower LDL-C 
and 1.0% (0.4, 1.5%) lower ApoB levels, adjusted for covariates. There were no 
quadratic relationships between length of gestation and lipid concentrations (all P 
>0.1). 
Table 18. Geometric means (geometric SD) of lipid levels in adolescent girls and boys 
born early and late preterm and controls born at term, and mean percentage 
differences (95% CIs) between preterm groups and controls adjusted for age. 
Measurement Early preterm Late preterm  Controls 
Geometric 
mean (SD) 
Mean percentage 
difference (95% CI) 
Geometric 
mean (SD) 
Mean percentage 
difference (95% CI) 
Geometric 
mean (SD) 
Girls       
Total 
cholesterol 
4.46 (1.18) 2.5 (-2.8, 8.1) 4.39 (1.46) 0.9 (-2.5, 4.5)  4.36 (1.19) 
HDL-C 1.54 (1.23) 5.6 (-0.5, 12.1) 1.46 (1.22) 0.2 (-3.6, 4.2)  1.46 (1.21) 
LDL-C 2.21 (1.34) -0.8 (-8.1, 7.2) 2.27 (1.26) 2.0 (-3.0, 7.2)  2.24 (1.29) 
ApoA1 1.45 (1.13) 2.9 (-1.3, 7.2) 1.42 (1.126) 0.3 (-2.4, 3.1)  1.41 (1.15) 
ApoB 0.67 (1.34) 1.5 (-5.4, 8.9) 0.67 (1.24) 1.2 (-3.4, 6.0)  0.66 (1.27) 
Triglycerides 0.72 (1.64) -7.4 (-18.2, 4.7) 0.80 (1.55) 3.3 (-4.6, 11.9)  0.77 (1.49) 
Boys       
Total 
cholesterol 
4.46 (1.18) 6.7 (0.2, 13.7) 4.39 (1.19) 2.2 (-1.0, 5.5)  4.36 (1.19) 
HDL-C 1.54 (1.24) -0.1 (-7.1, 7.4) 1.46 (1.22) -2.6 (-6.1, 1.0)  1.46 (1.21) 
LDL-C 2.21 (1.34) 11.7 (2.1, 22.3) 2.27 (1.26) 4.4 (-0.2, 9.3)  2.24 (1.29) 
ApoA1 1.45 (1.13) 0.9 (-3.6, 5.7) 1.42 (1.16) -1.0 (-3.3, 1.3)  1.41 (1.15) 
ApoB 0.67 (1.3) 12.3 (3.1, 22.4) 0.67 (1.24) 5.0 (0.5, 9.6)  0.66 (1.27) 
Triglycerides 0.72 (1.64) 19.2 (2.1, 39.1) 0.80 (1.56) 13.2 (4.7, 22.4)  0.77 (1.49) 
Abbreviations: ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; HDL-C, high-density lipoprotein cholesterol; 
LDL-C, low-density lipoprotein protein cholesterol. 
Boys born EPT-SGA had 17.6% (95% CI 2.9, 30.2) lower TC, 24.7% (95% CI 
3.2, 41.4) lower LDL-C levels, and 24.5% (95% CI 5.1, 40.0) lower ApoB levels 
than boys born EPT-AGA. We found no difference between boys born LPT-SGA 
compared to boys born LPT-AGA in lipid levels. In addition, after excluding 
those born SGA, among boys born early preterm, levels of TC were 10.4% (95% 
CI 2.7–18.6%) higher, those of LDL-C 19.3% (7.7–32.2%) and those of ApoB 
18.0% (7.2–29.9%) higher than in their controls. In addition, we reran the 
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analysis with adjustment only for birth weight SD score to assess the effect of 
birth weight separately from the effect of other covariates: In boys born early 
preterm, TC was 5.4% (-1.0–2.2%) higher, LDL-C was 10.3% (0.9–20.6%) 
higher, ApoB was 8.7% (-0.2–18.4%) higher and TGs 16.7% (0.1–35.9%) higher 
compared with controls. In boys born late preterm TG levels were 12.8% (4.2, 
22.0%) higher. To assess the effect of maternal gestational disorders and 
hypertensive pregnancy disorders, we reran the analyses after 1) excluding 
subjects exposed to maternal gestational diabetes and 2) excluding those exposed 
to maternal hypertension or preeclampsia, and the results remained similar. 
Moreover, after further adjustment for a) maternal gestational diabetes, b) 
preeclampsia and gestational or chronic hypertension with other covariates, the 
results again remained similar. 
5.4.2 Lipid profile of young adults born preterm (III) 
In the ESTER study, women born early preterm had lower HDL-C and ApoA1 
concentrations than the control women when adjusted for age and cohort (Table 
19). The differences attenuated when further adjusted for covariates (BMI, 
parental educational attainment, maternal smoking during pregnancy, parental 
history of hypertension, diabetes and acute myocardial infarction or stroke, self-
reported physical activity, daily smoking, birth weight SD score and hormonal 
contraception, direct effect model): Levels of HDL-C were 7.2% (1.1, 12.9%) 
lower and those of ApoA1 7.7% (2.3, 12.8%) lower in the early preterm group 
compared with controls. No differences in triglyceride or total or LDL-cholesterol 
concentrations were found in women born preterm compared with controls. 
Associations between preterm birth and lipid profile were not present among men. 
Within the subjects, no one used lipid-lowering medication. 
We further compared adults born EPT-SGA to adults born EPT-AGA, and adults 
born LPT-SGA to those born LPT-AGA, and no statistically significant difference 
was found between groups. In addition, after exclusion of those born SGA or those 
exposed to maternal antenatal disorders, or additional adjustment for maternal 
antenatal disorders, the results remained similar. 
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Fig. 14.  Mean percentage differences and 95% confidence intervals (error bars) in 
lipid levels in adolescent girls and boys and young adult women and men born early 
preterm compared with controls (zero line) adjusted for age, and in adults of the 
source cohort (the Northern Finland Birth Cohort 1986 or the Finnish Medical Birth 
Register.  
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Fig. 15. Mean percentage differences and 95% confidence intervals (error bars) in lipid 
levels in adolescent girls and boys and young adult women and men born late preterm 
compared with controls (zero line) adjusted for age, and in adults of the source cohort 
(the Northern Finland Birth Cohort 1986 or the Finnish Medical Birth Register).  
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Table 19. Geometric means (geometric SD) of lipid levels in young adult women and 
men born early and late preterm and controls born at term, and mean percentage 
differences (95% CIs) between preterm groups and controls adjusted for age, sex and 
cohort (NFBC or FMBR). 
Measurement Early preterm Late preterm  Controls 
 Geometric 
mean (SD) 
Mean percentage 
difference (95% 
CI) 
Geometric 
mean (SD) 
Mean percentage 
difference (95% 
CI) 
 Geometric 
mean (SD) 
Women       
TC 4.58 (1.16) -2.3 (-7.0, 2.6) 4.68 (1.17) -0.4 (-4.2, 3.7)  4.70 (1.20) 
HDL-C 1.59 (1.27) -11.4 (-16.9, -5.6) 1.73 (1.23) -3.2 (-8.1, 2.0)  1.79 (1.24) 
LDL-C 2.70 (1.31) 1.3 (-6.6, 9.8) 2.66 (1.28) 0.0 (-6.4, 6.8)  2.66 (1.35) 
ApoA1 1.53 (1.23) -9.7 (-14.7, -4.5) 1.65 (1.20) -2.9 (-7.3, 1.7)  1.69 (1-21) 
ApoB 1.53 (1.-23) 1.5 (-5.6, 9.2) 0.75 (1.24) -0.1 (-5.9, 6.0)  0.75 (1.31) 
LPa, mg/l 99,9 (3.24) 4.9 (-25.5, 47.7) 88.7 (2.98) -6.5 (-29.5, 23.9)  93.9 (3.25) 
Triglycerides 0.97 (1.56) 1.5 (-11.3, 16.1) 1.01 (1.58) 5.1 (-5.8, 17.2)  0.97 (1.61) 
Men       
TC 4.49 (1.23) 1.3 (-4.3, 7.2) 4.55 (1.20) 2.6 (-2.0, 7.5)  4.46 (1.22) 
HDL-C 1.36 (1.25) -1.2 (-7.3, 5.2) 1.32 (1.21) -4.1 (-8.9, 0.9)  1.37 (1.26) 
LDL-C 2.76 (1.49) 0.0 (-8.8, 9.6) 2.91 (1.32) 6.3 (-1.4, 14.6)  2.76 (1.37) 
ApoA1 1.35 (1.15) -1.7 (-5.8, 2.7) 1.34 (1.14) -2.0 (-5.5, 1.5)  1.36 (1.17) 
ApoB 0.77 (1.38) 1.8 (-5.9, 10.1) 0.80 (1.27) 5.6 (-1.0, 12.6)  0.76 (1.31) 
LPa, mg/l 85.8 (3.25) -4.9 (-33.0, 34.8) 94.4 (3.17) 2.4 (-23.1, 36.4)  91.0 (3.19) 
Triglycerides 0.95 (1.63) 6.4 (-6.5,21.0) 0.95 (1.56) 5.9 (-4.7, 17.6)  0.90 (1.51) 
Abbreviations: ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; HDL-C, high-density lipoprotein 
cholesterol; LDL-C, low-density lipoprotein protein cholesterol; LPa, lipoprotein (a); TC, total cholesterol. 
5.5 Glucose regulation (II, III) 
5.5.1 Glucose metabolism of adolescents born preterm (II) 
We found statistically significant interaction between late preterm birth and sex on 
HOMA-IR values (P=0.036) in the adolescents, so we analyzed the differences 
separately in girls and boys (NFBC). Girls did not show any difference in fasting 
plasma glucose or serum insulin levels, or in HOMA-IR values, compared with their 
controls.  
Boys born late preterm had higher insulin HOMA-IR values than boys born at 
term (Table 20). The differences became attenuated when adjusted for age, BMI, 
height, birth weight SD score, maternal smoking during pregnancy, educational level 
of the more educated parent, smoking of the subject, physical activity and Tanner 
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Pubertal Stage. The mean levels of fasting plasma glucose were similar between the 
groups. When adjusted only for birth weight SD score, in boys born late preterm, 
fasting insulin levels were13.2% (3.1, 24.3%) higher and HOMA-IR values 12.6% 
(2.6, 23.6%) higher than in controls. Otherwise, within the boys born early preterm or 
boys born late preterm, there was no statistically significant difference between SGA 
and AGA in glucose metabolism. In addition, after exclusion of those born SGA or 
those exposed to maternal antenatal disorders, or additional adjustment for maternal 
antenatal disorders, the results remained similar. 
Table 20. Geometric means (geometric standard deviations, SDs) concerning glucose 
metabolism in adolescent girls and boys born early and late preterm, and controls 
born at term, and mean percentage differences (95% CIs) between preterm groups and 
controls adjusted for age. 
 Early preterm Late preterm Controls 
 Geometric 
mean (SD) 
Mean percentage 
difference  
(95% CI) 
Geometric 
mean (SD) 
Mean percentage 
difference  
(95% CI) 
Geometric 
mean (SD) 
Girls      
fP-gluk 
(mmol/l) 
5.0 (1.08) -0.2 (-3.3, 3.0) 5.1 (1.13) 1.1 (-1.0, 3.2) 5.0 (1.11) 
fS-insulin 
(mU/l) 
9.8 (1.46) 0.2 (-11.2, 13.1) 10.2 (1.53) 5.7 (-2.4, 14.1) 9.8 (1.49) 
HOMA-IR 1.26 (1.52) 0.2 (-13.1, 15.6) 1.31 (1.52) 4.5 (-4.6, 14.4) 1.26 (1.49) 
Boys      
fP-gluk 
(mmol/) 
5.3 (1.09) 0.9 (-2.4, 4.3) 5.3 (1.08) -0.7 (-2.4, 1.0) 5.3 (1.10) 
fS-insulin 
(mU/l) 
9.9 (1.46) 5.5 (-10.6, 24.5) 10.9 (1.70) 13.8 (4.7, 23.7) 9.6 (1.59) 
HOMA-IR 1.37 (1.95) 14.1 (-8.0, 41.5) 1.42 (1.66) 13.2 (3.2, 24.3) 1.26 (1.58) 
Abbreviations: fP-gluk; fastin plasma glucose; fS-insulin, fasting serum insulin; HOMA-IR, homeostasis 
model assessment for insulin resistance. 
5.5.2 Glucose metabolism of young adults born preterm (III) 
No statistically significant interaction between preterm birth and sex on glucose 
metabolism was found in young adults born preterm. Two subjects of the ESTER 
study born late preterm reported having type 2 diabetes, so we excluded them from 
the analyses of glucose metabolism. Adults born early preterm had 15.5% (-0.1, 33.6) 
higher 2-hour serum insulin levels, but the difference was not statistically significant 
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(Table 21). Otherwise, adults born early preterm showed no differences in glucose 
metabolism outcomes compared with controls born at term. Adults born late preterm 
had 10.1% (1.9, 19.0%) higher fasting and 16.5% (3.0, 31.7%) higher 2-hour insulin 
concentrations, and 9.8% (1.6, 18.6) higher HOMA-IR indices than the controls when 
adjusted for age, sex and cohort. These differences became statistically non-
significant when controlled for parental and prenatal factors (parental educational 
attainment, maternal smoking during pregnancy, parental history of hypertension, 
diabetes, myocardial infarction or stroke), or intermediate factors (BMI, self-reported 
physical activity, daily smoking and birth weight SD score). Fasting and 2-hour 
glucose concentrations were similar in all groups. Eight (3.3%) of the late preterm 
subjects and 11 (3.2%) of the controls had impaired glucose tolerance (fasting glucose 
6.0 to 6.9 mmol/l and/or 2-hour glucose 7.8 to 11.0 mmol/l) and one (0.4%) subject 
born late preterm was found to have diabetes (fasting glucose >7.0 and/or 2-hour 
glucose >11.0) in oral glucose tolerance tests (OGTTs). Adults born EPT-SGA had 
71.3% (95% CI 16.3, 151.9) higher 2-hour insulin than adults born EPT-AGA. 
Otherwise, there was no statistically significant difference in glucose metabolism 
between EPT-SGA and EPT-AGA subjects or LPT-SGA and LPT-AGA subjects. We 
further reanalyzed the data by 1) excluding those born small for gestational age, 2) 
excluding those born in connection with a multiple pregnancy, and 3) further 
adjusting the analyses for maternal gestational diabetes. This did not alter any of the 
conclusions of the glucose metabolism. 
Table 21. Geometric means (geometric SD) concerning glucose metabolism in young 
adults born early and late preterm and controls born at term, and mean percentage 
differences (95% CIs) between preterm groups and controls adjusted for age, sex and 
cohort (NFBC or FMBR). 
Measuremennt Early preterm Late preterm  Controls 
 Geometric 
mean (SD) 
Mean percentage 
difference (95% CI)
Geometric 
mean (SD) 
Mean percentage 
difference (95% CI) 
 Geometric 
mean (SD) 
fP-gluk 5.17 (1.09) 0.8 (-0.8, 2.4) 5.17 (1.10) 0.3 (-1.0, 1.6)  5.14 (1.09) 
P-gluk 2h 4.90 (1.34) -0.4 (-3.9, 3.2) 4.96 (1.29) 1.1 (-1.8, 4.0)  4.86 (1.27) 
fS-insulin 7.27 (1.66) 8.8 (-1.0, 19.6) 7.40 (1.63) 10.1 (1.9, 19.0)  6.65 (1.51) 
S-insulin 2h 24.89 (2.14) 15.5 (-0.1, 33.6) 25.08 (2.09) 16.5% (3.0, 31.7)  21.73 (2.04) 
HOMA-IR 0.95 (1.66) 8.9 (-0.9, 19.7) 0.96 (1.63) 9.8 (1.6, 18.6)  0.87 (1.51) 
Abbreviations: fP-gluk; fastin plasma glucose; fS-insulin, fasting serum insulin; HOMA-IR, homeostasis model 
assessment – insulin resistance; fP-gluk 2h, 2-hour plasma glucose; fS-insulin 2h, 2-hour serum insulin. 
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5.6 Other metabolic biomarkers (III) 
In addition to conventional risk factors, we studied emerging risk factors that may 
reflect specific pathophysiological pathways, such as uric acid, markers of 
inflammation and markers of fatty liver (Table 22). In the ESTER study, subjects born 
preterm were 8- to 13-fold more likely to have an intermediate or high fatty liver 
index, a proxy of non-alcoholic fatty liver disease: 3.9% of subjects born early 
preterm, 2.5% of subjects born late preterm and 0.3% of the controls had an 
intermediate or high fatty liver index. However, the ORs were statistically significant 
in early preterm group only. Of the individual markers of fatty liver disease, plasma 
concentrations of alanine aminotransferase were 15.0% (95% CI 6.4, 24.2%) higher 
and those of aspartate transaminase were 11.7% (5.5, 18.2%) higher in those born late 
preterm, but the differences were not statistically significant.  
Table 22. Geometric means (geometric SD) concerning cardiometabolic biomarkers in 
young adults born early and late preterm and controls born at term, and mean 
percentage differences (95% CIs) between preterm groups and controls adjusted for 
age, sex and cohort (NFBC or FMBR). 
Measurement Early preterm Late preterm Controls 
Geometric 
mean (SD) 
Mean 
difference a 
(95% CI) 
Geometric 
mean (SD) 
Mean 
difference a 
(95% CI) 
Geometric 
mean (SD) 
Fasting plasma uric acid 
(µmol/l) 
314.3 (80.9) 20.1  
(7.9, 32.2) 
313.4 (74.5) 20.1  
(10.7, 30.5) 
291.7 (68.7) 
High-sensitivity C-
reactive protein, mg/l 
1.19 (3.95) -3.4%  
(-24.6, 23.7) 
1.01 (3.59) -9.4  
(-25.9, 10.7) 
1.15 (3.59) 
Blood leukocytes, 109/l 6.06 (1.31) 5.5%  
(0.0, 11.2) 
5.89 (1.29) 3.1%  
(-1.2, 7,7) 
5.67 (1.29) 
Plasma alanine 
aminotransferase, U/l 
25.5 (1.63) 9.3%  
(-0.6, 20.1) 
26.6 (1.69) 15.0%  
(6.4, 24.2) 
23.2 (1.67) 
Plasma aspartate 
transaminase, U/l 
22.9 (1.34) 5.6%  
(-1.5, 13.2) 
24.2 (1.43) 11.7%  
(5.5, 18.2) 
21.7 (1.44) 
Plasma albumin, g/l 47.1 (2.7) 0.6 (0.08, 1.0) 46.4 (2.4) -0.1 (-0.5, 0.3) 46.5 (2.7) 
Plasma gamma 
glutamate, U/l 
19.1 (1.84) 3.5%  
(-6.7, 14.8) 
19.4 (1.81) 5.7%  
(-2.8, 15.0) 
18.4 (1.68) 
Plasma urea, mmol/l 5.44 (1.8) 0.3 (0.0, 0.5) 5.13 (1.1) 0.0 (-0.2, 0.2) 5.1 (1.3) 
aMean differences are percentages except for fasting plasma uric acid, plasma albumin and plasma urea. 
Concentrations of plasma uric acid, another marker of metabolic syndrome, were 
20.1% (7.9, 32.2%) higher in the subjects born early preterm and 20.1% (10.7, 
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30.5%) higher in the late preterm group. In addition, plasma albumin 
concentrations were 0.6 g/l (0.08, 1.0) higher and plasma urea concentrations 
were 0.3 mmol/l (0.0, 0.5) higher in those born early preterm than in the controls, 
but the difference was not statistically significant when adjusted for the model 
used to assess the total effect of preterm birth (BMI, parental educational 
attainment, maternal smoking during pregnancy, parental history of hypertension, 
diabetes and myocardial infarction or stroke, self-reported physical activity, daily 
smoking and birth weight SD score). As for markers of inflammation, the levels 
of blood leukocytes were 5.5% (0.0, 11.2) higher in those born early preterm, but 
the difference was not statistically significant when adjusted for covariates. 
However, no difference in high-sensitivity C-reactive protein levels was found 
between adults born preterm and controls, except for 18.8% (0.4, 33.4) lower 
levels in the late preterm group when adjusted for the model used to assess the 
direct effect of preterm birth.  
5.7 Metabolic syndrome (III) 
Of the 711 subjects of the ESTER study who were included in the analysis, 46 
(6.5%) fulfilled the criteria of metabolic syndrome. Of the controls, 12 (3.5%) had 
the syndrome (Fig. 16). Among those born early preterm, the number was 15 
(11.5%), the odds ratio compared with controls being 3.97 (95% CI 1.76–8.62) 
adjusted for sex, age and cohort. Among those born late preterm, the number was 
19 (7.9%), odds ratio 2.5 (95% CI 1.2–5.43). The results were similar when 
further adjusted for covariates. 
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Fig. 16.  Prevalence of hypertension, obesity, metabolic syndrome and fatty liver 
index >30 in adults born early and late preterm versus adults born at term (controls). 
Printed with permission; the same figure appears in Am J Epidemiol. 2015: In press. 
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6 Discussion 
We found that adolescents and young adults born preterm show enhancement of 
cardiometabolic risk factors in several pathophysiological pathways (Fig. 17). While 
the results of previous studies have suggested that those born smallest and most 
immature have elevated levels of cardiometabolic risk factors, our study shows that 
some of these risk factors are also present in the much larger group of people born 
less preterm. Most of these risk factors were not explained by maternal pregnancy 
disorders, size at birth, socioeconomic status, current body size, or lifestyle. Although 
low birth weight is associated with later cardiometabolic risk factors, subjects born 
preterm and SGA did not have different cardiometabolic risk factors in adolescence or 
adulthood than subjects born preterm, except lower REE, lower SBP and DPB in 
adolescence, and higher 2-hour insulin than adults born preterm and AGA. However, 
the number of subjects born SGA is quite low for subgroup analysis. 
6.1 Body size and composition (I–III) 
Adolescents born preterm had similar body sizes and composition as their peers born 
at term (NFBC 1986, II). Nevertheless, young adults born early and late preterm have 
higher rates of obesity and higher waist circumferences than their peers born at term 
(the ESTER study, III). However, previous findings have shown that adults born 
severely preterm tend to be shorter compared with those born at term (Saigal et al. 
2006, Indredavik Evensen et al. 2009) and tend to have a lower BMI as a result of 
lower lean body mass and similar fat percentages (Hovi et al. 2007, Parkinson et al. 
2013). The early preterm group in our analysis included only 46 (34.3%) subjects 
born with VLBW (<1500 g), which may explain the difference between our study and 
previous ones. This is supported by the findings of other studies that have included 
subjects with all degrees of preterm birth and which have revealed higher BMI in 
adults born preterm compared with controls (Lewandowski et al. 2013, Mathai et al. 
2013). The results of our study and others suggest that very preterm birth has a 
different effect on adult body size in comparison with late preterm birth. 
Obesity, particularly abdominal obesity, is a key component underlying many 
characteristics of metabolic syndrome and is a major health problem throughout the 
world. The WHO defines obesity as abnormal or excessive fat accumulation that 
presents a risk to health and it is commonly classified according to BMI. The 2010 
Global Burden of Disease Study ranked high BMI among the four leading risk factors 
for disability-adjusted life years in the Americas, Europe, the Middle East and
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Australasia, and in recent decades it has increased the global disease burden by 
81% (Lim et al. 2012). Much of this burden is associated with an increased risk of 
cardiometabolic conditions. Numerous studies have shown an association 
between obesity and various cardiovascular disease risk factors, such as diabetes, 
hypertension, and dyslipidemias (Kopelman 2000, Mokdad et al. 2003). An 
overweight condition in youth might have particularly long lasting impacts on 
future health: being overweight in youth is associated with increased risks of type 
2 diabetes, hypertension, dyslipidemia and carotid-artery atherosclerosis in later 
life (Juonala et al. 2011, Koskinen et al. 2014).  
BMI is a convenient marker of overweight conditions and obesity, but it is an 
imperfect indicator of body fat, explaining only 25% of its variation. BMI also 
reflects LBM, which has associations with a number of outcomes including all-cause 
mortality (Gallagher et al. 1996). Thus, we also assessed body composition by means 
of bioelectric impedance and showed that adults born preterm had a higher fat mass 
and a higher percentage of body fat, and the difference compared with controls was 
more pronounced in the late preterm group than in the early preterm group. The 
finding is consistent with the results of previous studies on body size and composition 
of former preterm infants. Studies with subjects born very preterm or with VLBW 
have revealed lower LBM, but no difference in fat mass (Peralta-Carcelen et al. 2000, 
Hovi et al. 2007), or no difference between preterm group and controls (Weiler et al. 
2002, Rotteveel et al. 2008a), whereas those studies with subjects born less preterm 
have shown a more adipose body composition (Breukhoven et al. 2012, Lewandowski 
et al. 2013, Mathai et al. 2013). Additionally, in a recent meta-analysis it was 
determined that there were no differences in fat percentages; again, this is likely to 
reflect adults born severely preterm, as the mean gestational age of those born preterm 
was 30.6 weeks (Parkinson et al. 2013), whereas the mean GA in the subjects born 
early preterm was 31.8 weeks (SD 2.0) and in subjects born late preterm 35.8 weeks 
(SD 0.8). 
Our findings were not explained by socioeconomic status, maternal smoking 
during pregnancy, birth weight SD score or antenatal disorders. However, we did not 
have the growth data to investigate the effects of early growth on adult body size and 
composition in the ESTER study. Catch-up growth in the first years of life is more 
pronounced in weight gain than in growth in length, and may lead to altered body 
composition. Epidemiological life-course studies have shown that a small body size at 
birth and suboptimal early growth have an effect on cardiovascular and 
cardiometabolic disorders in later life (Barker et al. 2005, Eriksson et al. 2006, 
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Huxley et al. 2007, Whincup et al. 2008). In addition to neonatal medical conditions, 
infant growth is usually determined by nutrition in infancy. In the Helsinki study of 
Very Low Birth Weight Adults, nutrient intake in the first three weeks of life, 
especially higher energy, protein and fat intake, predicted higher LBM in adulthood 
(Matinolli et al. 2014). The important role of early nutrition is supported by the 
results of many animal studies, in which alterations in early nutrient intake produce 
considerable life-long effects on risk factors of adult obesity and cardiometabolic 
conditions (Gluckman et al. 2007, Robinson & Fall 2012, Desai et al. 2013). 
Unfortunately, processing of the data on early nutrient intake in the NFBC 1986 and 
the ESTER study was unfinished, and we were not able to use the data in the analysis. 
Lifestyle factors, such as physical activity and daily smoking, did not clarify the 
picture as regards altered body composition in adults born preterm.  
6.2 Resting energy expenditure (I) 
Body size and composition, especially lean body mass (LBM) have an influence on 
an individual’s energy expenditure: LBM explains about 60% of the variation of REE 
between individuals (Johnstone et al. 2005). Low energy expenditure may lead to 
obesity (Ravussin et al. 1988, Astrup et al. 1999). We found that adults born preterm 
with VLBW had lower REE, but higher REE per unit lean body mass. The difference 
was not explained by differences in body fat percentage, smoking, childhood 
socioeconomic status or physical activity, and it seemed to be associated with VLBW 
birth per se rather than any related perinatal conditions. The association between 
preterm birth and later energy expenditure is not well studied. In accordance with the 
results of previous studies comparing those born with low versus normal birth weight 
(Eriksson et al. 2002, Kensara et al. 2006), we found that the lower REE in VLBW 
adults is largely attributable to their lower LBM. Although the higher REE/LBM ratio 
in VLBW adults implies that they may have more metabolically active tissue than the 
controls, previous studies of organ size have suggested that the metabolically most 
active organs are particularly small in VLBW adults, for example the kidneys 
(Keijzer-Veen et al. 2010a) and brain (Martinussen et al. 2009, Taylor et al. 2011). 
With DXA and calorimetry we were unable to distinguish whether differences in the 
REE/LBM ratio are due to higher metabolic rate of some specific organs or an overall 
increase in metabolic rate in adults born with VLBW.  
Within the VLBW group, subjects born SGA had lower REE, but similar 
REE/LBM ratios as those born AGA when adjusted for age and sex. Our finding is 
consistent with that in a previous study in which children born preterm and SGA had 
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lower REE (Sepúlveda et al. 2013). Another study, however, showed that children 
born preterm and SGA had lower REE/LBM ratios (Mericq et al. 2009) than their 
peers born preterm and AGA. Within the VLBW group individuals born SGA and 
AGA differ in the conditions experienced before birth, although they have similar 
experiences after preterm birth. It is therefore possible that the long-term effects of 
adverse conditions during the period after preterm birth override those related to the 
conditions leading to preterm birth, such as intrauterine growth restriction. However, 
this should be interpreted with caution, since the study has limited power for 
subgroup analyses such as comparison of those born SGA and AGA. Nevertheless, 
the fact that an early growth pattern is important is also supported by our finding that 
the change in weight standard deviation score from preterm birth to term birth was not 
related to REE or the REE/LBM ratio, although a higher weight attained at 40 
postmenstrual weeks (term) was related to higher REE through its association with 
LBM. 
One possible factor affecting altered energy metabolism in adulthood might be 
early nutrition. After this study, data on early nutrient intake during the first nine 
weeks of life of subjects born with VLBW were collected from the hospital records 
and the association between early nutrient intake and adult REE and the REE/LBM 
ratio was evaluated. Nutrient intake in the first weeks of postnatal life was 
substantially below current recommendations. The lower energy, protein and fat 
intake was associated with lower REE but a higher REE/LBM ratio. This supports the 
view included in the DOHaD hypothesis that materno-fetal undernutrition influences 
the metabolic phenotype later in life so that undernutrition during early life increases 
metabolic activity, resulting in more active energy metabolism in adulthood 
(Matinolli et al. 2014). This might explain at least part of the difference in REE in 
adults born preterm with VLBW compared with their peers born at term. In addition, 
a higher REE/LBM ratio might protect adults born with VLBW from obesity, but this 
might not be the case in adults born less preterm. We were not able to measure REE 
in the ESTER study. To our knowledge, no investigators have measured or reported 
REE in adults born moderately or late preterm. 
6.3 Blood pressure (II–IV) 
We have shown that early preterm birth is associated with higher levels of blood 
pressure in adolescent girls and young adults. Findings in most previous studies are 
similar (Pharoah et al. 1998, Irving et al. 2000, Kistner et al. 2000, Doyle et al. 2003, 
Hovi et al. 2007, Rotteveel et al. 2008a, Indredavik Evensen et al. 2009, Keijzer-
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Veen et al. 2010b, Vohr et al. 2010, Thomas et al. 2011). In contrast, we did not find 
any statistically significant association between late preterm birth and BP. The 
association has not been clear in studies that have included subjects born less preterm 
(Barros & Victora 1999, Singhal et al. 2001b, Järvelin et al. 2004a, Johansson et al. 
2005, Dalziel et al. 2007, Cooper et al. 2009, Lazdam et al. 2010, Rossi et al. 2011, 
Skilton et al. 2011, Tauzin et al. 2014). However, we found an inverse linear 
association between GA and BP, which has been shown only in a few other studies 
(Siewert-Delle & Ljungman 1998, Leon et al. 2000, Järvelin et al. 2004b, Dalziel et 
al. 2007). Increased BP in children and adults born preterm has also been shown in 
two meta-analyses (de Jong et al. 2012, Parkinson et al. 2013).  
6.3.1 Ambulatory blood pressure and variability of blood pressure 
In connection with the ESTER study, we found that young adults born early preterm 
have higher mean BP in ABP measurements than their peers born at term. The 
difference was present when both awake and asleep, but it might be more pronounced 
when awake. In previous studies the difference has been smaller, for example 2.4–4.7 
mmHg higher 24-hour SBP in children and adults born preterm (Doyle et al. 2003, 
Hovi et al. 2010, Keijzer-Veen et al. 2010b, Roberts et al. 2014). In contrast to 
previous studies (Doyle et al. 2003, Hovi et al. 2010) and the results of a meta-
analysis (Parkinson et al. 2013) with gender-specific investigation, the difference was 
greater in men than in women in our study. Ambulatory measurement of BP is 
considered to be a more reliable approach to assessing blood pressure, because it is 
less affected by the anxiety response, but it also includes responses to environmental 
and lifestyle factors, such as physical activity (Verdecchia 2000, Kamarck et al. 2002, 
Clement et al. 2003).  
We also found higher individual variability of ABP in early preterm adults than 
in their controls. There are only a few studies that have reported variability of ABP in 
former preterm individuals and the findings are parallel (Hovi et al. 2010, Gunay et 
al. 2014). Variability of BP is a key factor underlying the progression of organ 
damage (Parati 1987, Frattola 1993), and the triggering of vascular events (Clement et 
al. 2003). It also correlates with the development of hypertensive left ventricular 
hypertrophy (Parati & Valentini 2006). 
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6.3.2 Sex-specific analysis 
We found higher blood pressure in adolescent girls, but not in boys compared with 
their peers born at term. In contrast, in ABP measurements in young adults the 
differences were larger among men born preterm. This was seen in particular for the 
adults born late preterm, in contrast to previous studies concentrating on those born at 
an earlier gestational age. A few studies have presented gender-specific analyses and 
most of them revealed a greater difference in women than in men (Doyle et al. 2003, 
Järvelin et al. 2004b, Hack et al. 2005, Cooper et al. 2009), but not all (Rotteveel et 
al. 2008a, Thomas et al. 2011). Statistically significant interaction between preterm 
birth and sex on blood pressure was seen in the Northern Finland Birth Cohort 1966 
(Järvelin et al. 2004b) as well as in our NFBC 1986 study, but not in the ESTER 
study. Most previous studies have shown that masked hypertension is more common 
in men (Bobrie et al. 2008, Hänninen et al. 2011), while white-coat hypertension is 
more common in women (Ben-Dov et al. 2008). However, because of a lack of 
statistical power, we could not test this in our data. It is possible that the contradictory 
results in sex-specific BP analyses can be in part explained by men reacting 
differently to factors related to office measurement, such as psychosocial stress, and 
factors captured by the 24-h recording, such as subject’s physical activity. 
6.3.3 Hypertension  
Adolescents born early preterm were more likely to have prehypertension and young 
adults born early preterm were more likely to have office-measured or daytime 
hypertension in ABP than adults born at term. However, the OR for hypertension was 
not statistically significant in adults born late preterm. Although an association 
between preterm birth and BP has been reported in several papers, only a few studies 
have reported more manifest hypertension in adults born preterm (Johansson et al. 
2005, Dalziel et al. 2007, Crump et al. 2011b). Our subjects are relatively young, and 
the association between preterm birth and blood pressure could be clearer later in life. 
At least the association between low birth weight and blood pressure seems to 
increase with age (Law et al. 1993).  
Hypertension is a major risk factor of ischemic heart disease and stroke. It is one 
of the most important causes of premature death worldwide (Mendis et al. 2011) and 
a leading risk factor as regards the global disease burden, accounting for 9.4 million 
deaths per year worldwide (Lim et al. 2012). A 3 to 5 mmHg increase in BP has been 
translated into an estimated increase in cardiovascular deaths of 25% and a 32% 
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increase in stroke (Yusuf et al. 2000, Law et al. 2003). The magnitude of increased 
BP in young adults born preterm is therefore notable. 
6.3.4 Possible mechanisms 
Hypertension has previously been attributed to an unfavorable genotype and lifestyle, 
for instance an unhealthy diet, physical inactivity, smoking and stress. However, there 
is strong evidence that early life factors such as preterm birth have an influence on 
increased blood pressure later in life. Our findings were not explained by 
socioeconomic status, lifestyle, body size or perinatal factors such as maternal 
pregnancy disorders, maternal smoking or IUGR. However, gender, parental 
educational attainment and maternal hypertension during pregnancy had the greatest 
and statistically significant influence on adult blood pressure in those born preterm. In 
our study maternal hypertension during pregnancy was associated with about 6 
mmHg higher 24-hour ambulatory SBP in young adults born preterm, but it did not 
explain the whole difference in BP compared with controls born at term. It has been 
suggested that there is a common genetic background to preterm birth and 
hypertension that partially explains elevated BP levels in former preterm infants. 
However, a large twin study has shown that the twin with lower birth weight is more 
likely to have hypertension in later life (Bergvall et al. 2007), suggesting that body 
size at birth is related to later blood pressure.  
Renal, vascular (e.g. arterial stiffness) and central regulatory (alteration of the 
hypothalamic-pituitary-adrenal axis) factors have been suggested to be involved in the 
developmental programming of BP (Nuyt 2008). At the time when preterm infants are 
born, nephrogenesis in the kidney is still ongoing, with the majority of nephrons 
normally formed from week 20 until 34 to 36 weeks of gestation (Hinchliffe et al. 
1991), so it is possible that there are changes in the structural development of the 
kidney in preterm infants such as smaller kidney size (Keijzer-Veen et al. 2010a) and 
lower number of nephrons (Rodriguez et al. 2004). These changes may be related to 
higher BP levels in adolescents and adults born preterm.  
Changes in vascular structure (Kistner et al. 2002, Lewandowski et al. 2013) and 
endothelial dysfunction or arterial stiffness in adolescents and adults born preterm 
(Bonamy et al. 2005, Bassareo et al. 2010, Hovi et al. 2011) have been suggested to 
be related to the higher BP levels as well as changes in the HPA axis (Kajantie & 
Raikkonen 2010). However, in the HeSVA, adults born preterm with VLBW had 
lower HPA-axis responses (Kaseva et al. 2014b) and similar or lower norepinephrine 
responses (Kaseva et al. 2014a) to psychosocial stress, arguing against a major role of 
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these systems in mediating BP levels or variability in adults born preterm (Kajantie & 
Raikkonen 2010). In addition, it has been shown that BP in adulthood is affected by 
maternal nutrition during pregnancy (Roseboom et al. 2001, Hult et al. 2010, Gubhaju 
et al. 2011), and postnatal nutrition might also have an effect on later BP in preterm 
infants (Singhal et al. 2001a). Catch-up growth, with rapid weight gain, may lead to 
higher BP (Rotteveel et al. 2008b, Vohr et al. 2010). However, the specific 
mechanism behind elevated BP still remains unclear. 
6.4 Lipid metabolism (II, III) 
Our findings concerning the association of preterm birth and lipid metabolism are 
inconsistent, as they have been in previous studies (Hovi et al. 2007, Lewandowski et 
al. 2013, Mathai et al. 2013, Parkinson et al. 2013). In adolescence, boys born early 
preterm had higher levels of serum TC, LDL-C and ApoB than boys born at term, and 
boys born late preterm had higher levels of TGs. However, we found no difference in 
girls born preterm compared with girls born at term. In contrast, women born early 
preterm had lower levels of HDL-C and its precursor ApoA1 than women born at 
term, but we found no difference in lipid levels in men. 
Several investigators have reported no association between preterm birth and 
serum lipid levels in adolescence or adulthood (Irving et al. 2000, Kistner et al. 2004, 
Finken et al. 2006, Rotteveel et al. 2008a, Hovi et al. 2011, Skilton et al. 2011, 
Thomas et al. 2011). However, there are also studies that have shown more 
atherogenic lipid profiles in former preterm infants, such as higher LDL-C and TG 
levels than in their peers born at term (Lewandowski et al. 2013, Parkinson et al. 
2013), lower HDL-C and higher total cholesterol concentrations, and differences in 
lipid levels after a meal (Rotteveel et al. 2008a) or as assessed in detailed lipid 
profiling by way of metabolomics (Hovi et al. 2013). Differences similar to those that 
we found in women born early preterm compared with women born at term have not 
been reported in previous studies. However, in a Finnish study, SGA subjects (mean 
age 20 years) had higher serum levels of LDL-C and higher LDL-C/HDL-C ratios, 
and lower HDL-C concentrations than AGA subjects. In the SGA group, total and 
LDL cholesterol levels correlated inversely with adult height SD score (Salonen et al. 
2010). 
The unfavorable lipid profile in boys born preterm was not explained by slow 
fetal growth or other antenatal factors. The difference was even stronger when boys 
born SGA were excluded, but was attenuated slightly when adjusted for birth weight 
SD score. This suggests that the higher rates of slow fetal growth among those born 
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preterm could in part underlie the higher plasma lipid concentrations in boys born 
preterm. In addition, slow fetal growth can have similar sex-specific associations as 
preterm birth as regards lipid profile later in life. Previous studies have shown male-
specific association between low birth weight and serum LDL-C levels in adolescents 
(Kuzawa & Adair 2003) and TC in young adults (Mogren et al. 2001). In addition, 
among the general population, low birth weight is associated with elevated levels of 
TC among men, but not in women in meta-analysis (Lawlor et al. 2006b). The 
mechanisms behind these sex-specific differences are not known. A part of the 
difference could be explained by the differences in sex hormones and body 
composition between women and men. The unfavorable lipid profile in adolescent 
boys born preterm was not explained by socioeconomic status measured by parental 
education, lifestyle (smoking or physical activity) or pubertal stage.  
The difference in HDL-C and ApoA1 levels between women born preterm and 
women born at term was not explained by perinatal factors, because it remained 
similar when controlled for these factors. Part of the difference, but not all, was 
explained by current body size and lifestyle, because it was attenuated when adjusted 
for BMI, physical activity and daily smoking.  
ApoB is the primary apolipoprotein component of LDL-C and it is independently 
associated with increased risk of metabolic syndrome (Onat et al. 2007, Koskinen et 
al. 2012). In addition, elevated LDL-C levels in youth (at 12–18 years age) predicted 
coronary artery calcification in adulthood in the Young Finns Study (Hartiala et al. 
2012). Decreased HDL-C levels are one of the key factors of metabolic syndrome. 
Dyslipidemias are major risk factors of ischemic heart disease and stroke, and high 
total cholesterol is one of the leading risk factors as regards death and disease (Lim et 
al. 2012). Our findings suggest that adolescents and adults born preterm may have 
altered lipid metabolism. 
6.5 Glucose regulation (II, III) 
Boys born late preterm had higher fasting insulin levels and HOMA-IR values than 
controls; otherwise we did not find any differences between adolescents born preterm 
and controls in outcomes used to assess glucose metabolism. In adults, late preterm 
birth was associated with elevated fasting and 2-hour insulin levels and HOMA-IR 
values, but not with glucose levels. Studies in prepubertal children (Hofman et al. 
2004, Kistner et al. 2012) and young adults (Dalziel et al. 2007, Hovi et al. 2007, 
Pilgaard et al. 2010, Mathai et al. 2012) born preterm have shown lower insulin 
sensitivity, as clearly indicated by intravenous (Hofman et al. 2004) and oral glucose 
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tolerance tests, and also higher fasting insulin levels (Hovi et al. 2007). Although our 
subjects were born at grater gestational weeks, they had parallel adverse metabolic 
characteristics associated with impaired glucose regulation as those born severely 
preterm. However, the differences we found in adults were smaller than in the 
Helsinki Study of Very Low Birth Weight Adults (Hovi et al. 2007). 
The DOHaD theory suggests that when a fetus is developing under suboptimal 
conditions, it adapts to guarantee immediate survival by preserving vital functions at 
the expense of other less immediately critical functions. For example, to preserve 
glucose for vital organs it induces peripheral insulin resistance, thus disturbing the 
development of other organs such as the kidneys and pancreas (Hales & Barker 
2001). The differences in glucose metabolism in adolescents born late preterm versus 
their peers born at term was not explained by perinatal factors such as maternal 
pregnancy disorders. When adjusted only for birth weight SD score, the differences 
were even greater. However, the differences in glucose metabolism between adults 
born preterm and controls were not statistically significant when adjusted for parental, 
prenatal and lifestyle factors. A main contributing factor to impaired glucose 
regulation among adults born less preterm may be increased body fat with ectopic 
distribution. In contrast, in the smallest preterm individuals, a main contributing 
factor to impaired glucose regulation may be low muscle mass.  
Abnormally low insulin sensitivity is called insulin resistance, which means that 
tissues resist the activity of insulin on a regular basis, disabling efforts to remove 
glucose from the circulation. The results of various prospective epidemiological 
studies across several population groups indicate that type 2 diabetes progresses over 
a continuum of worsening insulin action, beginning with peripheral insulin resistance 
and ending with a loss of insulin secretion (Saltiel 2000). Our subjects in both studies 
were young, and as expected, few of them fulfilled the criteria of type 2 diabetes or 
impaired glucose tolerance. Studies in older adults have suggested that higher rates of 
type 2 diabetes occur in those born preterm (Lawlor et al. 2006a, Indredavik Evensen 
et al. 2009, Kaijser et al. 2009, Kajantie et al. 2010a). In addition to type 2 diabetes, 
insulin resistance predicts atherosclerosis and cardiovascular events independently of 
other risk factors including fasting glucose and lipid levels (Hanley et al. 2002). 
Our study shows that abnormal metabolic characteristics are already present in 
young adults. Our findings, together with the results of previous studies, are 
consistent with the hypothesis that preterm birth is associated with type 2 diabetes 
later in life.  
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6.6 Other metabolic biomarkers (IV) 
Along with the conventional components of metabolic syndrome we found 
alterations in a wide range of biomarkers that reflect different underlying 
pathophysiological pathways. Uric acid concentrations were over 20% higher in both 
the early- and late-preterm groups than in the controls. Uric acid stimulates oxidative 
stress, endothelial dysfunction, inflammation and vasoconstriction and is a well-
established strong predictor of type 2 diabetes and cardiovascular disease, 
independent of other metabolic syndrome components (Fang & Alderman 2000). We 
are unaware of any previous studies reporting uric acid concentrations in adults born 
preterm. 
Levels of liver transaminases were also higher in adults born preterm, and the 
participants with a moderate or high fatty liver index, which is a proposed marker of 
non-alcoholic fatty liver disease (NAFLD) (Bedogni et al. 2006), were almost all born 
preterm. Previous studies have not reported liver transaminases in adults born 
preterm. NAFLD is one cause of a fatty liver, occurring when triacylglycerol-rich 
lipid droplets are deposited (steatosis) in the hepatocytes without excessive alcohol 
use. However, NAFLD is usually diagnosed by ultrasonographic imaging and the 
fatty liver index is an estimated value used to predict NAFLD, and based on BMI, 
waist circumference, triglycerides and gamma glutamate: an FLI <30 rules out and an 
FLI ≥60 rules in hepatic steatosis as detected by ultrasonographic imaging (Bedogni 
et al. 2006). It may not reveal all cases of non-alcoholic fatty liver disease, because 
the prevalence of NAFLD in our study was relatively low, being 20–30% in Western 
European countries (subjects aged 20–83 years) (Targher et al. 2010) and 18.5% in 
Finnish adults (34–49 years of age) (Suomela et al. 2014), and the prevalence is 
higher in obese versus normal-weight adults. However, the subjects in these studies 
were older, which may explain the difference in prevalence. Liver transaminases and 
non-alcoholic fatty liver disease also predict cardiometabolic disorders, although the 
literature is less consistent, as they are better independent indicators of pathology 
rather than general markers of metabolic syndrome (Sniderman et al. 2011, Lv et al. 
2013) and strong risk factors of type 2 diabetes (Fan et al. 2007, Yun et al. 2009).  
Chronic subclinical inflammation is part of metabolic syndrome (Festa et al. 
2000). As for markers of inflammation, levels of blood leukocytes were higher in 
those born early preterm, but the difference was not statistically significant when 
adjusted for covariates. In contrast, adults born late preterm had lower levels of high-
sensitivity C-reactive protein when adjusted for parental, prenatal and lifestyle factors 
and BMI. In addition, adults born early preterm had higher plasma albumin and urea 
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concentrations, but the difference was not statistically significant when adjusted for 
parental and prenatal factors. Previous studies have shown a positive association 
between serum albumin and blood pressure levels (Hostmark et al. 2005) and 
metabolic syndrome (Ishizaka et al. 2007, Cho et al. 2012). However, an inverse 
relationship between serum albumin concentrations and cardiovascular disease 
mortality has also been reported (Phillips et al. 1989). In addition to kidney function, 
the plasma urea level can be an indicator of liver function, nutrition, and plasma 
volume. 
6.7 Metabolic syndrome (II, III) 
In addition to elevated cardiometabolic risk factors in several pathophysiological 
pathways, adults born preterm were 8- to 13-fold more likely to fulfill the criteria of 
metabolic syndrome. This has not been reported in other studies before. The overall 
prevalence of metabolic syndrome in our study population was 6.4%; as it was 1.7–
2.4% in 16-year old adolescents in Northern Finland in 2001–2002 (Pirkola et al. 
2008), and it was 10–15% in Finnish adults aged 24–39 years in 2001 and it increases 
with age (Mattsson et al. 2007). As mentioned before, metabolic syndrome is a 
combination of factors that multiply a person's risk of heart disease, diabetes and 
stroke (Lakka et al. 2002, Onat et al. 2002). It has been suggested that as the number 
of cardiovascular risk factors increases, so does the severity of asymptomatic 
coronary and aortic atherosclerosis in young people (Lewandowski et al. 2014). 
6.8 Limitations and strengths of the studies 
The present work is based on data from three different studies (HeSVA, NFBC 1986, 
the ESTER study) with a wide spectrum of outcome measurements. An important 
strength of the HeSVA study population is the prospective cohort with controls 
matched by age, sex and birth hospital. However, the sample size of subjects born 
with VLBW or early preterm is relatively small, but still the same size or larger than 
in most previous studies. The main strength of the NFBC 1986 and the ESTER 
studies is the study populations, which were chosen to include the whole range of 
preterm births in a specific geographic area. The participation rate in the ESTER 
study was relatively low, and selection bias cannot be excluded in either of the 
studies. For example, adolescents born preterm were less likely to participate in the 
NFBC 1986 clinical examination at 16 years of age, and it is possible that subjects 
with impairments associated with preterm birth are underrepresented. In the ESTER 
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study, there was some difference in the proportion of the late preterm and control 
groups recruited through the NFBC or the FMBR, for which reason we adjusted for 
the recruitment cohort. Nevertheless, detailed non-participant analysis did not raise 
any major concerns as regards selection bias in any of the studies. Moreover, while 
we had sufficient power for most outcomes, power was limited for more rare 
outcomes, such as moderate or high fatty-liver index. In addition, the number of 
subjects born early preterm was too small for detailed subgroup analysis of maternal 
pregnancy disorders or other SGA vs. AGA comparisons.  
The subjects of the studies were born in the 1970s and 1980s, and they are the 
first generation whose gestational age at birth has been increasingly confirmed with 
ultrasonographic imaging. We paid particular effort in the NFBC 1986 and ESTER 
studies to determine the lengths of gestation as accurately as possible. However, the 
treatment of prematurely born infants in neonatal intensive care was different in the 
1970s and 1980s than it is nowadays. Nevertheless, they represent a big population 
group of today’s adults that have been exposed to deviant circumstances in the 
perinatal period and are now at a higher risk of developing disease. Today’s 
prematurely born infants have lower rates of morbidity and mortality in childhood, 
and it is possible that they have lower rates of cardiometabolic risk factors in 
adulthood. However, the associations between preterm birth and later cardiometabolic 
risk factors were not explained by the medical conditions and treatment in the 
neonatal period. Therefore, some of these cardiometabolic risk factors might exist in 
today’s infants born preterm. On the other hand, our subjects are still too young to 
allow study of the association between preterm birth and manifest cardiovascular 
disease, and our findings are limited to early markers of cardiovascular disease. 
Nevertheless, we have shown that young adults born early preterm have more 
hypertension and metabolic syndrome than their peers born at term. 
Another strength of the study is the comprehensive measurement of conventional 
and emerging cardiometabolic risk factors. However, not all participants underwent 
calorimetry and DXA; in HeSVa the availability of ABP monitoring was limited, and 
not all subjects were willing to wear the equipment in the ESTER study. Therefore, 
indirect calorimetry and ABP measurement were performed in subgroups of the 
original cohorts. It is possible that these subgroups were not representative of the 
original cohort. Furthermore, some subjects did not wear an accelerometer, and we 
could not objectively determine their awake and sleep periods. This factor may 
increase inaccuracy and lead to a more conservative estimate. Moreover, some of the 
confounders and intermediate factors, such as parental history of disease, medication, 
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physical activity, smoking and pubertal stage were self-reported and some missing 
values exist, which may further introduce inaccuracy.  
Although we adjusted for several key confounders, there is a possibility of 
residual confounding. For example, we had no data to distinguish between 
spontaneous and medically-indicated preterm birth. Instead, we relied on proxy 
measures, such as SGA or maternal hypertension in pregnancy, that, nevertheless, are 
likely to cover a major proportion of indicated preterm deliveries. These things may 
have resulted in less precise estimates. In addition, we did not have data on early or 
current nutrition or growth, so we were unable to assess the effect of these factors on 
cardiometabolic risk in adolescence or in adulthood. Further, collider stratification 
bias is possible when intermediate factors, such as BMI, physical activity and 
smoking are adjusted for in regression models; this is unlikely to have had any 
significant effect, as these adjustments had a negligible effect on the results.  
6.9 Significance of the findings and future perspectives 
Adolescents and adults born preterm, including those born late preterm, have elevated 
cardiometabolic risk factors in several pathophysiological pathways, including 
hypertension and metabolic syndrome, compared with their peers born at term. 
Together with the results of numerous previous studies, this may indicate a later risk 
of cardiometabolic disorders such as type 2 diabetes and coronary artery disease in 
adults born preterm. To date, previous studies have not revealed higher prevalence of 
metabolic syndrome, resting energy expenditure or elevated levels of liver 
transaminases in adults born preterm. Only a handful of previous studies have 
concerned ABP in adults born preterm, and those studies have focused on subjects 
born preterm with VLBW, or born very or extremely preterm, and even fewer have 
reported variability of blood pressure. In particular, the cardiometabolic health of 
adolescents and adults born late preterm has not been well studied. Many of the risks 
have dose-response relationships and these risks are increased in those born late 
preterm – in the group representing the majority of individuals born preterm. Timing 
of the interruption of development is important as regards later outcome. Some of the 
risk factors seem to be different in adolescents and adults born late preterm versus 
those born in early gestational weeks, for example a more adipose body composition 
and related factors. However, more studies on the cardiometabolic health of adults 
born late preterm are needed.  
Despite the large amount of evidence concerning elevated cardiometabolic risk 
factors in adults born preterm, most previous studies have failed to show an 
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association between preterm birth and coronary artery disease or cerebrovascular 
disease, although the risks of these diseases increase throughout life. The results of 
studies on elderly people cannot be easily translated to infants born in recent decades, 
because of the improvements in NICUs and, for example, the nutrition of preterm 
infants. In addition, preterm infants born several decades ago were less likely to 
survive to adulthood – survival was more selective than it is today. Therefore, longer 
follow up is needed to investigate whether or not adults born preterm and treated in 
modern NICUs have more cardiometabolic diseases. 
In spite of the significant number of studies in humans and animals, the 
mechanisms linking preterm birth and adult diseases are still incompletely 
understood, probably because the pattern is so intricate. Theory of DOHaD proposes 
that circumstances in utero (e.g. mother’s nutrition, psychosocial stress, pregnancy 
disorders) or during infancy (e.g. disturbed development of organs, nutrition, growth, 
neonatal morbidity and treatments) may induce changes in body size and structure, 
metabolism, hormone secretion and gene expression. Those experiences during 
critical periods of early development may have consequences on cardiometabolic 
health through a lifespan. In addition to early life factors, there are several 
intermediated factors in childhood and youth that may influence to cardiometabolic 
risk factors in later life such as socioeconomic status including education, physical 
activity, and nutrition. The limited number of subjects in the cohorts has not allowed 
investigation of the mechanisms behind the risk and protective factors. For example, 
collaboration of investigators and pooled data sets might illustrate these mechanisms 
and throw light on the impact of all potential confounders. It has been suggested that 
some genetic determinants are associated with preterm birth as well as with 
cardiovascular diseases: Women with a history of premature labor have an elevated 
risk of cardiovascular disease (Robbins et al. 2014). Sibling studies may give more 
information as to whether or not there is a genetic background to these elevated risk 
levels (D'Onofrio et al. 2013). It would also be interesting to investigate the impact of 
early nutrition and growth on our findings, and whether they can be explained by 
epigenetic mechanisms (Hanson et al. 2011Hanson et al. 2011, Wehkalampi et al. 
2013). Although the mechanisms are unclear, the present data support the DOHaD 
theory that developmental influences have lifelong effects on cardiovascular and 
metabolic function. 
Most of the cardiometabolic risk factors related to preterm birth are modifiable. 
Favorable early life circumstances of premature infants, such as optimal nutrition and 
reduction of stress in neonatal intensive care units, might reduce the risk of later 
cardiometabolic disorders. In addition, children and adults born preterm might 
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particularly benefit from primary prevention such as screening of risk factors and 
promotion of a healthy lifestyle. 
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7 Conclusions 
1. Adults born preterm show enhancement of cardiometabolic risk factors 
concerning several aspects such as body size and composition, energy 
metabolism, blood pressure, glucose and lipid metabolism, and some 
emerging cardiometabolic risk factors. They also have a 2.5- to 4-fold greater 
risk of full-blown metabolic syndrome than those born at term.  
2. Some of the risk factors are already elevated in adolescence, for example 
blood pressure in girls and LDL cholesterol and apolipoprotein B levels in 
boys born before 34 weeks of gestation. 
3. These risks are also present in the large group of young adults born late 
preterm, which is consistent with a dose-response relationship between the 
degree of prematurity and metabolic syndrome. However, some of the risk 
factors might be different in those born late preterm, such as adipose body 
composition, and lower insulin sensitivity.  
4. Preterm birth may have a different effect as regards cardiometabolic risk 
factors in females and males, for example in blood pressure and lipid 
metabolism. 
5. Most of these elevated levels of risk factors are not attributable to lower 
socioeconomic status, parental history of cardiovascular disease, maternal 
pregnancy disorders, birth weight SD score, current body size, or life style. 
6. In conclusion, adolescents and adults born preterm may be at a greater risk of 
developing cardiometabolic disorders in later life. Adolescents and adults 
born preterm benefit from a healthy lifestyle, especially because the 
cardiometabolic risk factor baseline seems to be higher than in those born at 
term.  
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